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ABSTRACT
DEVELOPING AN INSULIN PRODUCING TISSUE USING MOUSE
EMBRYONIC STEM CELLS
by
Neha Mahendrakumar Jain
This thesis describes derivation of pancreatic insulin producing cells (IPCs) from mouse
embryonic stem cells and development of three-dimensional (3D) engineered tissue
system to provide physiologic culture conditions for IPCs. Upon using a previously
established protocol, IPCs have been successfully derived from mouse embryonic stem
cells and characterized in vitro. IPCs not only express classical markers of pancreatic beta
cells but also exhibit glucose responsive behavior. Interestingly while deriving IPCs from
mouse embryonic stem cells, islet endothelial cells have also been identified and
successfully isolated from the culture. Derivation of a pure population of endothelial cells
expressing specific markers of islet microvasculature, differentiated from mouse
embryonic stem (mES) cells is entirely novel and is demonstrated for the first time in this
study. To better mimic the native environment, a 3D engineered tissue system has been
created using stem cell-derived IPCs. IPC survival, glucose responsiveness and gene
expressions under both static and flow culture conditions were examined. Furthermore,
the effects of endothelial cells on IPC function was examined using a 3D co-culture
system of IPCs and islet endothelial cells under both static and flow culture conditions.
While no significant improvements are seen in the glucose responsiveness and
gene expression analysis of the IPC clusters in 3D culture conditions in static or flow
culture conditions, this study describes includes preliminary design considerations that

can be further extended in developing functional 3D insulin-producing tissues, and
ultimately establishing a long-term clinically relevant strategy.
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CHAPTER 1
INTRODUCTION

1.1 Background
Diabetes is an epidemic disease that affects about 371 million people worldwide [3]. In
the United States alone, diabetes has been reported as the 7th leading cause of death, with
the total economical cost of $245 billion in 2012 [7]. Diabetes is also a major cause of
various other diseases including heart disease, kidney failure, non-traumatic lower limb
amputations, blindness, dental disease and complications during pregnancy among adults
[10].
Pancreas transplantation has been considered the gold standard for treatment of
diabetes type I. But, due to shortage of healthy donor tissue available, transplantation of
pancreas or islets is extremely limited. Even if the transplantation is performed, immune
rejection poses a serious problem to the health of the patient. Most patients need to be on
life long immune suppression drugs, which compromise their health and wellbeing.
Xenografts i.e., animal derived tissue are comparatively readily available for
transplantation, but pose a serious risk of unknown disease transmission if used for
transplantation. Alternatively, insulin injections are used by a majority of the patients
suffering from diabetes Type I & II, but these can lead to hypoglycemia or
hyperglycemia which themselves can cause major health issues, including death [11].
Further, insulin injections provide temporary relief of symptoms while not addressing the
underlying cause.
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Recently, islet transplantation has emerged as one of the promising treatment
options. Isolated islets are encapsulated inside semipermeable membranes and then
transplanted or simply delivered inside the body through a catheter [12]. This is a simpler
procedure compared to the pancreas transplantation as the volume of islets is much less
than the pancreas [13]. In addition, the encapsulation prevents the islets from being
destroyed by the body’s immune system [13, 14]. Recently, the Edmonton protocol for
islet transplantation has been described [15]. The Edmonton protocol involves isolating
islets from a cadaveric donor pancreas using a mixture of liberases. Each recipient
receives islets from one to as many as three donors. The islets are infused into the
patient's portal vein, and are then kept from being destroyed by the recipient's immune
system through the use of two immunosuppressants, sirolimus and tacrolimus as well as a
monoclonal antibody drug used in transplant patients called daclizumab [15]. But, the
islet transplantation by Edmonton protocol has shown that the islets suffer from low
retention and viability after transplantation [15]. As multiple donors are needed for
providing islets for one patient, this further limits the procedure. There are other obstacles
to successful microencapsulated islet transplantation such as deficient nutrient diffusion,
local fibrosis and issues with biocompatibility [16, 17]. All these factors indicate the need
for achieving a large pool of functional beta cells and providing a physiological
environment for these cells in vitro, which can be used for therapeutic intervention for
patients with diabetes.
To better understand the pathophysiology of diabetes, Type 1 and 2 diabetes are
reviewed in Section 1.1.1. The physiology of pancreatic islet cells is summarized in
Section 1.1.2. Recent efforts in deriving stem cell-derived pancreatic islet cells are
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described in Section 1.1.3. Furthermore, section 1.1.4 describes the past and current
efforts in the field of pancreatic tissue engineering. The several interactions that occur
between the beta cells and endothelial cells during development have been described in
Section 1.1.5.
1.1.1 Diabetes
The term diabetes mellitus describes a metabolic disorder characterized by chronic
hyperglycemia with disturbances of carbohydrate, fat and protein metabolism resulting
from defects in insulin secretion, insulin action, or both. The effects include long term
damage, dysfunction and failure of various organs [18]. There are several different types
of diabetes, among which diabetes Type 1 and Type 2 are the most common.
Type 1 diabetes is classified as Type 1A and Type 1B. Type 1A diabetes is caused
by autoimmune destruction of the beta cells of the pancreas [19]. The slowly progressive
form of diabetes type 1A generally occurs in adults and is sometimes referred to as latent
autoimmune diabetes in adults (LADA). Islet cell autoantibodies, and autoantibodies to
insulin, and glutamic acid decarboxylase (GAD65) are present in almost 85–90% of
patients with Type 1 diabetes mellitus [20]. It has been shown that genetic background,
ethnicity and environmental factors play a role in the disease occurrence [21]. Type 1B,
also known as the Idiopathic Type 1 diabetes is characterized by the absence of an
autoimmune disorder and diabetes related antibodies [22, 23]. It is known to have a
severe and sudden onset and is characterized by high serum pancreatic enzyme
concentrations [23]. It has been found that individuals of African and Asian origin are
more prone to getting affected by this disease [24].
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The current treatment options for patients with Type 1 diabetes include pancreas
transplantation and islet transplantation. Current limitation with the transplantation option
is the shortage of healthy donor organ/tissue. Typically more than one donor organ in
needed for each patient. This significantly increases the need for healthy donor tissue for
such

islet

transplant

options.

Moreover,

these

patients

require

continuous

immunosuppression. The immunosuppression is not only needed for preventing graft
rejection, but also to prevent the recurring autoimmune attack on the islets.
Another limitation is the low survival of transplanted islets. While Edmonton
protocol showed unprecedented success as 17 consecutive patients became insulin
independent after the treatment [15], only 10% of them maintained the insulin
dependence after 5 years [25]. Moreover, it has been reported that approximately 60% of
pancreatic islets are destroyed due to instant blood-mediated inflammatory reaction after
intraportal transplantation through a catheter [17]. This reaction leads to the disruption of
islets due to the activation of complement and coagulation systems [26, 27]. Further, the
devascularization caused during the isolation, as well as the implantation of the islets into
low oxygen tension within the liver, directly damages the islet cells [16]. The activation
of innate immune system by the hypoxia environment and the release of inflammatory
cytokines, such as tumor necrosis factor-α (TNF-α), interferon-γ (IFN-γ), and interleukin1 (IL-1) also leads to damage to the islet graft [28].
Type 2 diabetes, also known as non-insulin-dependent diabetes, or adult-onset
diabetes is a term used for individuals who have relative, rather than absolute, insulin
deficiency. Insulin resistance is often observed in patients with diabetes Type 2 [29, 30].
As the hyperglycemia is not severe enough to induce symptoms, diabetes Type 2 can go
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unnoticed for a long time [31, 32]. Nevertheless, this increases the risk for developing
macrovascular and microvascular complications [31, 32]. With the advent of science and
identification of specific pathogenetic processes and genetic defects that cause diabetes, it
is likely that the number of people in this category will decrease in the future [18].
Weight reduction, increased physical activity, and pharmacological treatment of
hyperglycemia have been shown to improve insulin resistance [33, 34]. The risk of
developing Type 2 diabetes increases with age, obesity, and lack of physical activity [35,
36]. It has been shown that women who suffered from gestational diabetes are more
likely to develop diabetes Type 2. Individuals suffering with hypertension and
dyslipidemia are also at increased risk for developing diabetes type 2 [35-38]. Familial
and genetic disposition play an important role [37-39]. However, the genetics of this form
of diabetes are complex and not clearly defined.
Most patients with diabetes type 2 are dependent on insulin injections to maintain
a normal blood glucose level. Although availability of insulin improves the symptoms of
the patient, administration of insulin is not a treatment for diabetes. Lifestyle change,
healthy eating habits, exercise, weight loss and medications such as Metformin are the
recommended treatment options [40]. Recently, increasing evidence has demonstrated
that islet and cell transplantation, which has only been applied to patients with Type I
diabetes, is also effective in patients with Type 2 diabetes [41].
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1.1.2 Pancreas and Pancreatic Cells

Figure 1.1 Anatomical Position of the Pancreas. The pancreas is shown in relation to the
liver, stomach, spleen and the duodenum. Adapted from Moses et al.
Source: [42].

The pancreas is a narrow, 6-inch long gland that lies posterior and inferior to the
stomach on the left side of the abdominal cavity [43]. Figure 1.1 shows the anatomical
position of the pancreas in relation to the surrounding organs such as stomach, liver and
the spleen. For descriptive purposes, it is divided into a head, neck, body and tail [6]. The
pancreas is a highly vascularized organ. There are numerous arteries that supply the
pancreas with freshly oxygenated blood as illustrated in Figure 1.2. The pancreas is
vascularized by the superior and inferior pancreatico-duodenal arteries, which form an
anastomosis between the coeliac and superior mesenteric arteries, and by numerous short
branches from the splenic artery.
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divisum’. (d) Absence of accessory duct (20%). (e) Conjoined drainage of
persistent ventral and dorsal ducts (<5%).

reach nodes at the roots of the coeliac and superior mesenteric
arteries.

It drains to nodes lying along the upper border of the gland and in
the groove between the pancreatic head and the duodenum to

Structure
The pancreas macroscopically is finely lobulated and is contained
within a delicate fibrous capsule. These lobules are made up of
alveoli of serous secretory cells, which drain via their ductules into
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Figure 2 Arterial supply of the pancreas.

Figure 1.2 Arterial Supply to the Pancreas.264Adapted from Moses et al.
Source: [6].
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The pancreas is the largest of the digestive glands and performs a range of vital
exocrine and endocrine functions. The pancreas macroscopically is finely lobulated and is
contained within a delicate fibrous capsule. These lobules are made up of alveoli of
serous secretory cells, which drain via their ductules into the principal ducts. The islets of
Langerhans are located between the alveoli and most of them are located in the pancreatic
tail. The islets of Langerhans taken together form ~1% of the pancreas [44] and studies
using microspheres have shown that they receive 10% of the total pancreatic blood flow
[45]. In most rodents, β cells compose the core of the islets and the non beta cells,
including α, δ and pancreatic polypeptide (PP) cells, form the mantle region [46-50].
However, in the human islets not only are the β cells lower in number compared to
rodents [51-53], they are dispersed throughout the islets [51, 54].
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Pancreatic beta cells play an important role in the maintenance of glucose
homeostasis in the body. This begins with the entry of glucose in the beta cells via the
GLUT2 receptor [55]. Glucose is then phosphorylated to glucose-6-phosphate by
glucokinase, which is also the main glucose sensor in the beta cell [56, 57]. Elevation in
the ATP/ADP ratio induces closure of ATP-sensitive potassium channels on the cell
surface leading to cell membrane depolarization [58]. This causes the voltage gated Ca2+
channels to open and facilitates the influx of Ca2+ inside the beta cell. A rise in free
Ca2+ levels in the cytoplasm trigger the exocytosis of insulin [59]. The primary action of
insulin, which is secreted by the beta cells, is to facilitate glucose uptake. This is done
primarily in three different ways. Initially, insulin signals the cells of insulin-sensitive
peripheral tissues, primarily skeletal muscle, to increase their uptake of glucose [60].
Secondly, insulin acts on the liver to promote glycogenesis. Finally, insulin
simultaneously inhibits glucagon secretion from pancreatic α-cells, thus signaling the
liver to stop producing glucose via glycogenolysis and gluconeogenesis [61]. Other
actions of insulin include the stimulation of fat synthesis, promotion of triglyceride
storage in fat cells, promotion of protein synthesis in the liver and muscle, and
proliferation of cell growth [62].
Amylin is a neuroendocrine hormone also secreted by beta cells in response to
nutrient stimuli [63-65]. Amylin complements the effects of insulin on circulating
glucose concentrations via two main mechanisms. Amylin suppresses glucagon secretion
after a meal [66], thereby decreasing glucagon-stimulated hepatic glucose output
following nutrient ingestion. This suppression of glucagon secretion is mediated via
efferent vagal signals. Importantly, amylin does not suppress glucagon secretion during
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insulin-induced hypoglycemia [67, 68]. Amylin also slows the rate of gastric emptying
and thus, the rate at which nutrients are delivered from the stomach to the small intestine
for absorption [69].
Glucagon is a key catabolic hormone secreted from the alpha cells in the islets.
Some studies have described diabetes as a bihormonal disease resulting from inadequate
insulin as well as excessive glucagon [70]. Glucagon regulates hepatic glucose
production and maintains basal blood glucose concentrations within a normal range
during the fasting state. When the level of glucose in plasma falls below the normal
range, glucagon secretion increases, resulting in hepatic glucose production and return of
plasma glucose to the normal range [71, 72]. This endogenous source of glucose is not
needed during and immediately following a meal, and glucagon secretion is suppressed.
1.1.3 Stem Cell Derived Pancreatic Cells
It has been shown that embryonic stem cells from both mouse [73-75] and human [73,
76-82] can be differentiated into pancreatic islet cells. Soria et al. first described the
derivation of insulin producing cells from mouse embryonic (mES) cells [83], while
Assady et al. demonstrated human embryonic stem (hES) cell derived insulin producing
cells for the first time [76]. Other studies have reported the effects of chemical factors
affecting the efficiency of differentiation. Some of these protocols used a serum free
ITSFn (Insulin, Transferrin, Selenium and Fibronectin) medium and basic fibroblast
growth factor (bFGF) treatments [84], while others involved treatment with PI3 kinase
inhibitors [85]. However, it was later shown that this protocol might trigger apoptotic
pathways of the cells and promote neuronal differentiation [77, 86]. Cells derived from
these protocols did not show a controlled insulin release or insulin positive secretory
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granules [77, 86, 87], indicating that they are immature and not fully functional under in
vitro culture conditions [5]. The cells produce insulin but are not able to upregulate their
insulin response when exposed to high glucose conditions. Upon transplantation of stem
cell derived IPCs to mice, they were able to transiently correct the glucose levels but the
effect faded in time [84, 85, 88]. This may be a result of cell death or de-differentiation
following transplantation. To increase the yield of endodermal cells, selection of nestin
positive cells has been used for both mES cells [79, 84-87, 89-92] and hES cells [87, 91,
93]. Teratoma formation is another drawback of this strategy, which makes it impractical
to be used as a clinical therapy [74, 85, 88].
Another approach is to use the knowledge derived from pancreatic development
to develop strategies for ESC differentiation into insulin producing cells. A five-stage
protocol that mimics pancreatic organogenesis and comprises the sequential phases of
inducing a definitive endoderm, primitive gut tube, posterior foregut, pancreatic
endoderm and cells that express endocrine hormones, was successfully used to
differentiate hES cells to IPCs [94]. After two weeks of differentiation, endocrine
hormone expression was noticed. The drawback to this approach was that most of the
cells co-expressed more than one hormone indicating that the cells produced were not
fully mature. Further, the yield of insulin producing cells was limited to ~7% and the Cpeptide release in response to a glucose challenge was marginal [94]. A similar multi
stage protocol was also developed using mES cells [84]. Two signaling pathways, the
Wnt and transforming growth factor TGF-β are crucial to induce formation of the
definitive endoderm. Previous studies have shown that differentiation of human ESCs
into definitive endoderm can be achieved via treatment with activin-A and Wnt3a and
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can be confirmed by expression of endodermal markers such as Sox17, FoxA2, Gata4,
Cxcr4, and Cerberus [94, 95]. Nodal, CHIR99021, IDE1 and IDE2 are molecules that
have been shown to induce development of the definitive endoderm in mouse [96, 97]
and human cells (19). Also, retinoic acid (RA) is a strong teratogen and can induce ES
cells into different cell types including neuronal [98], cardiac [99] and smooth muscle
cell [100] based on time and concentration of exposure.
Yet another protocol with four stages of differentiation and a timeline of 12 days
was developed that helped generation of glucose responsive insulin producing cells [95].
In brief, during the first stage, human ESCs were treated with activin-A and Wnt3a,
followed by activin-A treatment. In the second stage, cyclopamine treatment was
eliminated and keratinocyte growth factor was substituted for FGF10. In the next stage,
differentiating cells are treated with B27 (a proprietary serum free supplement by Life
Technologies), KAAD-cyclopamine, all-trans retinoic acid and Noggin instead of
Fibroblast growth factor (FGF). In the fourth stage (pancreatic endoderm formation),
cells were cultured in the absence of all factors except B27. Finally, the pancreatic
endoderm was transplanted into immunodeficient mice for an in vivo maturation step.
Although previous studies have focused on inducing the expression of PDX1,
which is a pancreatic progenitor marker by RA, the generation of insulin producing cells
was not increased [10] using this approach in mES cells. Some studies have also used a
combination of RA with activin A for mES cells, which has also been shown to lead to
both pancreatic and neuronal population [101]. Another strategy was to use conditioned
medium from embryonic pancreatic buds [102], but the variable composition of secreted
growth factors can have an impact on the differentiation process from mES cells. These
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challenges suggest that deriving a high yield of functional insulin producing cells from
mouse embryonic stem cells is a challenging process and requires a robust approach. Low
cell yield, low insulin secretion and lack of glucose responsiveness are the major
challenges that need to be overcome. Recently, in a breakthrough study Pagliuca et al.,
demonstrated the derivation of a large amount of functional human pancreatic beta cells
using ESCs [103]. This protocol is scalable and can be used for large-scale production of
glucose responsive insulin producing cells. Transplantation of these cells into diabetic
mice led to ameliorated hyperglycemia. However, more studies will need to replicate the
results before they can be used as a therapy.
Mesenchymal stem cells (MSCs) derived from human bone marrow have also
been shown to differentiate into insulin producing cells (IPCs) by induced expression of
PDX1 [104]. These cells were glucose responsive and were able to reduce hyperglycemia
upon transplantation, but only half of the differentiated cells expressed insulin, while
glucagon, somatostatin and ghrelin was expressed by all the differentiated cells [104].
Another study used adipose tissue derived MSCs to produce IPCs [105]. Upon induction
into a pancreatic endocrine phenotype, the cells expressed transcription factors important
for pancreatic development such as Isl-1, Ipf-1, and Ngn3.
1.1.4 Pancreatic Tissue Engineering
In the past, perifusion setups have been used for in vitro culture of islets prior to
transplantation. The term ‘perifusion’ is used to distinguish the design that involves the
flow of culture medium around the islets in a continuous-flow chamber, from the term
‘perfusion’ which involves flow of medium through an intact tissue [106]. In perifusion
studies, freshly isolated islets are freely suspended in a column. This column is typically
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under 95 % O2 and 5% CO2 exposure at 37 °C. Krebs ringer bicarbonate buffer with
different glucose concentrations is applied to stimulate insulin release from the islets. The
outflow of the column is collected and used for assays or saved for future use. Such
assays are typically done over short time intervals ranging from a few minutes to a few
hours.
Long term culture of islets in 2D condition have shown that endocrine cells
transdifferentiate into exocrine cells and undifferentiated cells [107]. Also, 2D tissue
culture surfaces do not provide the cell-matrix interactions that are present in vivo.
Perifusion methods were developed to improve survivability and function of islets after
isolation [108]. In perifusion studies, freshly isolated islets are freely suspended in a
column that is typically under 95 % O2 and 5% CO2 exposure at 37 °C. These systems
allow for rapid testing of the glucose sensitivity of the islets prior to transplantation.
Past studies have shown that islets or individual beta cells have improved
survival and function when cultured on ECM-derived substrates, both cell-secreted
matrices [109-115], and individual purified ECM proteins [113, 116-119]. Various ECM
components have been tested to improve the islet survival and function in in vitro culture.
It has been shown that matrix secreted by bovine corneal endothelial cells improved islet
survival [120], insulin secretion [121] and induced adult β-cell proliferation [109].
Studies of rat β-cells cultured on matrix produced using a rat bladder carcinoma line
(804G) revealed that the integrin α6β1 interacted with laminin in the 804G-secreted
matrix and influenced β-cell function and insulin secretion [122, 123]. Similar to studies
with cell-derived matrices, culture experiments with purified individual ECM proteins
resulted in better islet survival and function. Collagen type IV [118] and laminin [113],
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both components of the basement membrane, contributed to greater insulin release. Islets
cultured on collagen type I–coated surfaces and those treated with soluble fibronectin
exhibited less apoptosis and greater insulin secretion [119]. Vitronectin influenced β-cell
adhesion and migration via αv integrin interactions [117]. In most of these studies islet–
matrix interactions have been studied with insulin-producing cells cultured on 2D ECMcoated tissue culture surfaces. However, there is a growing interest in using ECM
components, such as collagens and Matrigel for forming three-dimensional (3D) gels,
allowing for the entrapment of islets or individual β-cells and the study of cell–matrix
interactions in 3D culture conditions.
Previous studies have demonstrated the encapsulation of xenobiotic islets in
semipermeable membranes prior to transplantation prevents the immune rejection by the
host animal while allowing insulin secretion out of the membrane and maintenance of
normal blood glucose levels [124-128]. The major obstacles to successful
microencapsulated islet transplantation are deficient nutrient diffusion, local fibrosis, and
the use of inadequate materials for capsules, thus compromising biocompatibility.
Further, islets to be implanted should be homogenously dispersed inside the capsules to
facilitate maximum oxygen and nutrient diffusion. It is important that the membrane is
permeable to insulin and low molecular weight components such as oxygen, glucose,
electrolytes and other nutrients and impermeable to cellular components of the immune
system.
Recently, three-dimensional islet culture experiments have been demonstrated by
a number of groups. Brendel et al., showed that human islets embedded in agarose gel
compared with islets in suspension culture were able to consistently induce
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normoglycemia in nude mice even after 14 days in in vitro culture [129]. Daoud et al.,
investigated the effects of human islet culture within various three-dimensional
environments including collagen I gel and collagen I gel supplemented with ECM
components fibronectin and collagen IV and found that the incorporation of ECM
components within the three-dimensional support significantly improved insulin release
profile and gene expression when compared to suspension culture [130].
Moreover, it was also shown that the entrapment of freshly harvested islets in a
3D collagen matrix helped maintain the islet integrity in culture as the contraction of
collagen fibrils counteracted the dispersion of islets [131]. It was observed that the
entrapped islets maintained satisfactory morphology, viability, and capability of glucosedependent insulin secretion for over two weeks [131]. A study by Wang et al., reported
the development of a 3D ESC pancreatic differentiation system to derive insulin
producing glucose sensitive cells. The study showed that about 50-60% of the
differentiated cells produce insulin. However, teratoma formation upon transplantation
was not studied.
Various microfluidic systems were explored in efforts to improve the survival of
islets in in vitro culture by perfusing islets and doing rapid quality assessment following
donor isolation [132]. Culturing mouse islets in a microfluidic device resulted in twice
the endothelial cell density inside the islets and connected length of capillaries compared
to classically cultured islets [133]. Microfluidic devices have also been used to perfuse
islets and doing rapid quality assessment following donor isolation [132]. Microfluidic
devices can serve as unique platforms to optimize islet culture by introducing
intercellular flow to overcome the restricted diffusion of media components. Microfluidic
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devices offer ease of operation, high customization abilities and the capability to do
single islet analysis [134-136]. At the same time, they also suffer from limitations such as
islet damage due to potential shear and mechanical stresses [134-136], complexity of
microfluidic devices [134-138], low throughput [137-140] and the difficulty of
monitoring/imaging the islets real time [132, 137, 138, 141].
1.1.5 Interaction of Pancreatic Cells and Vascular Cells
Islets are highly vascularized structures [142]. Although, islets form only 1-2% of the
pancreatic mass, they receive approximately 10% of the blood supply [143]. The blood
perfusion is meticulously regulated, predominantly [144] by a complex interplay of
locally produced factors, gastrointestinal hormones and the nervous system, to meet the
needs for hormone secretion imposed on the pancreatic tissue [143]. This not only allows
for adequate nutrient supply and glucose sensing, but also facilitates adequate and rapid
dispersal of islet hormones secreted to the blood stream.
It has been shown that various vascular mediated signals are important during
pancreatic development. In vitro tissue interaction studies have shown that the dorsal
aorta, which is near the dorsal pancreatic endoderm, induces the budding of the dorsal
pancreas and expression of pancreatic transcription factors such as the pancreatic and
duodenal homeobox 1 (Pdx1) transcription factor and pancreas transcription factor 1a
(PTF1a), as well as insulin and glucagon [145, 146], as shown in Figure 1.3. The aorta
also induces the dorsal pancreatic mesenchyme, which signals towards the dorsal
pancreatic bud via fibroblast growth factor 10 (FGF10) [147]. An important bloodderived factor is sphingosine-1- phosphate (S1P), which binds to G-protein-coupled S1P
receptors on mesenchymal cells and induces their proliferation. In turn, these
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mesenchymal cells stimulate growth and budding of the dorsal pancreatic endoderm
[148]. In summary, there is convincing evidence of the inductive potential of vascular
tissue during pancreatic development in mice that might also apply to human pancreatic
development [1].
Differentiating endocrine cells start to secrete vascular endothelial growth factorA (VEGF-A) to attract endothelial cells and induce them to form an islet vascular bed
[149].
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Figure 2. Interactions between EC and endocrine cells throughout life. Interactions between blood vessels and endocrine cells start early in the embryo. (a) Aortic EC (red)
induce pancreatic cell fate in the foregut endoderm (orange cells) marked by the expression of Pdx1 and Ptf1a. Mutual signaling between EC and developing endocrine cells
occurs thereafter. EC (red) are attracted (wiggly arrow) by endocrine secretion of VEGF-A (and probably Ang-1). In turn, the EC secrete basement membrane proteins such
as collagen-IV and laminins, which are essential for endocrine maturation (a-cells are denoted as blue and b-cells as green). During this process, CTGF is secreted by EC and
might play a role in b-cell lineage allocation. As the islet expands during fetal and postnatal life (and during normal islet maintenance), a fine-tuned balance between islet
mass and vessel density is maintained (red lines). Key players are VEGF-A secreted by b-cells and HGF produced by EC, which is trophic for endocrine cells. Moreover, islet
function is supported by EC-derived extracellular matrix molecules, such as laminins and collagen-IV. According to our hypothesis, capillaries grow under conditions of islet
growth such as pregnancy and obesity. (b) Under pathological conditions, capillaries might fail to expand or deteriorate owing to vascular inflammation, thus leading to bcell dysfunction and development of T2DM. Signaling molecules from blood vessels and endocrine cells are marked in red and blue, respectively.

Figure 1.3 Interactions Between Endothelial Cells and Endocrine Cells Throughout
Life. Adopted from Eberhard et al.
Source: [1].

Table 1. Molecular interactions between b-cells and blood vessels
Secreted molecule
b-Cells
VEGF-A
Ang-1
Tsp-1

Function

Receptor or target

References

VEGF-A165 dimer secretion by b-cells in embryo and adult and
EC attraction and maintenance
Angiogenic factor
Angiostatic factor; induction of apoptosis in EC and regulation
of blood vessel density

VEGFR2 on endothelial cells

[18–20]

[18] islet
It has been shown that VEGF-A is essential not only Tie-2
for development of the
CD36

[34]

Vasculature
microvasculature,
but also for the formation of endothelial fenestration, which might
Collagen IV
Laminins

Potentiation of insulin secretion
Induction of b-cell differentiation and normal insulin production,
secretion and b-cell proliferation
Potential role in endocrine lineage specification; expression
to a lesser extent in b-cells
Support of b-cell proliferation in embryonic and postnatal pancreas

Integrins
Integrins, Lutheran

[40]
[24,25,39]

facilitate
effective glucose sensing and interstitial flow inInteraction
the adult
islet [149-152].
with integrins
[26)
CTGF
HGF

c-Met

[28]

However, VEGF-A deficient mouse islets do not completely lack blood vessels, so other
460

factors might also contribute, to some extent, to endothelial cell attraction and vessel
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formation [150]. Angiopoietin-1 (Ang-1), another angiogenic growth factor expressed in
beta cells [149], promotes the survival and integrity of blood vessels [153].
Apart from enabling blood flow in islets, endothelial cells are the source of many
extracellular matrix (ECM) proteins that support beta cell differentiation and proliferation
[154, 155]. It has also been shown that a novel EC-derived factor, connective tissue
growth factor (CTGF), is involved in endocrine cell lineage allocation and beta cell
proliferation [156]. CTGF is highly expressed in the islet vasculature, albeit at lower
levels in future β cells in the embryonic pancreas. More α cells were found in islets of
CTGF-deficient mice, so CTGF might be required for directing endocrine precursor cells
towards the beta cell lineage. CTGF also interacts with several growth factor signaling
pathways, such as the TGF beta (Transforming growth factor beta) and Wnt pathways,
but its specific receptor in the pancreas has not been identified yet [156]. The various
molecular interactions between the endothelial cells and beta cells are tabulated in Table
1.1.
The beta cell and endothelial cell interaction continues even in adulthood. In the
healthy individual, the beta cell adapts to higher insulin demands, such as during
postnatal development, increased body weight (in extreme to obesity) or pregnancy, by
upregulation of insulin production and growth [157]. The growing islet requires oxygen
and nutrients, as well as paracrine signals from the blood vessels, so expansion of the
microvasculature is needed. This expanding microvasculature results from mutual signals
between blood vessels and beta cells. VEGF-A signaling is also essential for maintaining
the vascular bed in adult islets, because systemic administration of VEGF receptor
antagonists quickly and significantly reduced the islet vascular density [158].
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Apart from its role during embryonic pancreas development, VEGF-A also seems
to play a role in islets after birth. More specifically, VEGF-A has been suggested to
stimulate endothelial cell growth in the neonatal pancreas [159], because low perinatal
levels of VEGF-A were associated with reduced vascular density, early insulin secretory
defects and a decrease in beta cell mass in intrauterine growth restricted rats [160]. In
addition, increased levels of VEGF-A were observed during islet growth in pregnant rats
and it was shown that EC proliferation precedes beta cell division [159]. Thus, islet cell
mass expansion either during body growth from a neonate to an adult or during

Figure 2. Interactions between EC and endocrine cells throughout life. Interactions between blood vessels and endocrine cells start early in the embryo. (a) Aortic EC (red)
induce pancreatic cell fate in the foregut endoderm (orange cells) marked by the expression of Pdx1 and Ptf1a. Mutual signaling between EC and developing endocrine cells
occurs thereafter. EC (red) are attracted (wiggly arrow) by endocrine secretion of VEGF-A (and probably Ang-1). In turn, the EC secrete basement membrane proteins such
as collagen-IV and laminins, which are essential for endocrine maturation (a-cells are denoted as blue and b-cells as green). During this process, CTGF is secreted by EC and
might play a role in b-cell lineage allocation. As the islet expands during fetal and postnatal life (and during normal islet maintenance), a fine-tuned balance between islet
mass and vessel density is maintained (red lines). Key players are VEGF-A secreted by b-cells and HGF produced by EC, which is trophic for endocrine cells. Moreover, islet
function is supported by EC-derived extracellular matrix molecules, such as laminins and collagen-IV. According to our hypothesis, capillaries grow under conditions of islet
growth such as pregnancy and obesity. (b) Under pathological conditions, capillaries might fail to expand or deteriorate owing to vascular inflammation, thus leading to bcell dysfunction and development of T2DM. Signaling molecules from blood vessels and endocrine cells are marked in red and blue, respectively.

pregnancy are accompanied by increased VEGF-A expression to ensure a sufficient
density of capillaries within islets.

Table 1.1 Molecular Interactions Between Endothelial Cells and Beta Cells
Table 1. Molecular interactions between b-cells and blood vessels
Secreted molecule
b-Cells
VEGF-A
Ang-1
Tsp-1
Vasculature
Collagen IV
Laminins
CTGF
HGF

Function

Receptor or target

References

VEGF-A165 dimer secretion by b-cells in embryo and adult and
EC attraction and maintenance
Angiogenic factor
Angiostatic factor; induction of apoptosis in EC and regulation
of blood vessel density

VEGFR2 on endothelial cells

[18–20]

Tie-2
CD36

[18]
[34]

Potentiation of insulin secretion
Induction of b-cell differentiation and normal insulin production,
secretion and b-cell proliferation
Potential role in endocrine lineage specification; expression
to a lesser extent in b-cells
Support of b-cell proliferation in embryonic and postnatal pancreas

Integrins
Integrins, Lutheran

[40]
[24,25,39]

Interaction with integrins

[26)

c-Met

[28]

460
Source:
[1]
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Furthermore, studies have shown evidence that isolated islets in co-culture with
endothelial cells have shown better survival, integration and functionality [159, 161-164].
Although the participation of ECs in β-cell differentiation and function has been well
studied in vivo [1, 145, 154, 165, 166], the influence of these cells in the specific
differentiation of ESCs into insulin-producing β cells as well as the factors involved have
not been fully explored in vitro. A recent paper by Adame et al., showed that co-culturing
endothelial cells with differentiating embryoid bodies resulted in an increase in the
expression of the pancreatic markers PDX-1, Ngn3, Nkx6.1, Pro-insulin, GLUT-2 and
Ptf1a [167]. These studies suggest that endothelial cell mediated factors might play a very
critical role in the differentiation of stem cells into functional beta cells.

1.2 Significance
This thesis dissertation describes research in the field of pancreatic tissue engineering
with the goal of making fundamental advances in the development of functional
pancreatic tissues for basic research as well as for long-term clinical application to treat
patients with diabetes.
One of the main challenges in pancreatic tissue engineering is obtaining a large
number of functional insulin producing cells. Past studies have used various stem cell
sources and protocols to derive insulin-producing cells using pluoripotent stem cells.
Despite the considerable progress in the field of stem cells, the yield of insulin producing
cells using stem cells remains low at about 0.8-7.3% [94, 168]. Furthermore, cells are still
immature as they co-express more than one endocrine hormones and are not fully
responsive to glucose.
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Therefore, the overall objective of this dissertation was to establish a threedimensional (3D) engineered tissue system to provide a proper culture condition for stem
cell-derived beta cells to become fully functional in vitro. The effects of physical cues
including application of flow to 3D tissues were examined. In addition, the effects of
cellular factors on stem cell-derived islet cell function were examined by co-culturing
with endothelial cells. The overall objective was achieved by the following specific aims:
Specific Aim 1) To improve the survival and functionality of mES derived insulin
producing cells (IPCs).
Working Hypothesis: Encapsulation of IPCs in a 3D ECM environment will improve
their survival and glucose responsiveness.
a) Characterization of mES cell derived IPCs in a 2D system. IPCs will be derived
from mES cells and their phenotype and function will be examined using
techniques such as RT-PCR, immunohistochemistry, western blotting, and insulin
ELISA. Specifically, the expression of genes such as PDX1, Insulin, Pax4,
Nkx6.1, GLUT-2, EphrinA5 and GAPDH will be examined.
b) Characterization of mES cell derived IPCs in 3D system. The optimal density of
IPCs to be encapsulated in an ECM based gel will be determined based on
previous studies by other groups using islet cells. IPCs will be encapsulated in a
collagen hydrogel matrix. The IPC performance in the 3D systems will be
measured and compared to that of the 2D system based on cell survival and
glucose stimulated insulin release measured by insulin ELISA. The expression of
genes such as PDX1, Proinsulin, Pax4, Nkx6.1, EphrinA5, GLUT-2 and GAPDH
will be examined by using RT-PCR.
c) Effects of flow on IPC function and survival in a 3D gel system. The 3D gel
system will be subjected to perfusion flow using an existing flow bioreactor
system. The function of IPC in the 3D system will be assessed and compared in
static vs. flow conditions through protein and gene analysis.
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Specific Aim 2) To characterize the endothelial cell population derived from mES
cell differentiation into IPCs
Working Hypothesis: mESC-ECs derived from IPC differentiation protocol express islet
endothelial cell specific markers.
a) Characterization of mES -EC phenotype and function in a 2D culture. ECs will be
characterized in detail for expression of classic EC markers such as PECAM-1,
Thrombomodulin, ICAM-1, EphB2 and eNOS as well as islet endothelial cell
specific markers such as Nephrin and Anti alpha trypsin-1 (AAT).
b) Characterization of mESC-EC phenotype and function in a 3D engineered tissue.
3D hydrogel tissues will be formed using mESC-ECs and collagen type I (derived
from rat tail). They will be analyzed for formation of tubular networks, lumens
and deposition of ECM proteins such as laminin, collagen type IV and
fibronectin.
c) Effects of flow on 3D vascularized tissues. mESC-EC hydrogels will be subjected
to flow using an existing perfusion bioreactor system. A flow rate of 0.5 ml /min
which corresponds to a shear stress of approximately 0.71 dynes/cm2 will be used.
This value falls in the shear stress range that is estimated to be present in the
circulation [169]. These tissues will be analyzed for formation of tubular networks
and lumens.

Specific Aim 3) To develop a 3D vascularized insulin producing tissue.
Working Hypothesis: IPCs co-cultured with ECs will maintain higher viability, glucose
responsiveness and will have a higher expression of islet specific markers compared to
that of IPCs mono-cultured in collagen.
a) To develop a co-cultured 3D tissue with mES cell-derived insulin producing cells
and mESC-ECs. The cell and matrix densities will be optimized based on the
literature and experimental trials.
b) To characterize the effects of flow on a co-cultured 3D tissue on mES cellderived insulin-producing cell maturation and function. An existing perfusion
bioreactor system will be used for the application of flow to the 3D co-culture
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tissue construct. Flow parameters will be optimized based on the literature and
experimental trials. A static co-culture will be used as a control.
c) To study the expression profile of EphrinA5 in mES derived insulin producing
cells. The expression profile of EphrinA5 will be studied and compared under
flow and static co-culture condition and its co-relation to insulin secretion and
glucose responsiveness will be studied.

Derivation and characterization of IPCS from mES cells are described in Chapter
2. Extended from the studies in chapter 2, the techniques were devised to embed the IPCs
in collagen hydrogels. Characterization of the survivability and functionality of the IPCs
in 3D collagen tissue under static and flow culture condition is described in Chapter 3.
The co-culture of mESC-IPCs and mESC-ECs is also described in Chapter 3. The
derivation, isolation and characterization of islet specific endothelial cells from mES cells
in 2D and 3D conditions are described in Chapter 4. A summary of the entire work and
future directions are discussed in Chapter 5. This is the first demonstration of islet
specific endothelial cells derived from mouse embryonic stem cell, which is in press for
Cell Transplantation Journal. An appendix section includes details of all the protocols,
medium recipes and methods used.
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CHAPTER 2
DIFFERENTIATION OF MOUSE EMBRYONIC STEM CELLS INTO
PANCREATIC BETA CELLS
2.1 Introduction
Diabetes Mellitus is a chronic progressive metabolic disorder. Currently, pancreas or islet
transplantation is considered the best therapeutic option for Type I diabetes patients,
while most Type 2 diabetes patients depend on life long medication for maintaining
glucose homeostasis. However, several limitations to these treatments include side effects
of immune suppression drugs used during transplantation, immune rejection and the
dependency on medication. Further, there is a shortage of healthy donor organs, which
led scientists to investigate alternative methods to obtain suitable cell source for
transplantation. Recently, a number of studies have shown the possibility of deriving
insulin-producing cells using embryonic and adult stem cell populations as summarized
in Table 2.1 [75-77, 81, 170-172].
Soria et al., demonstrated the first derivation of insulin producing cells from
mouse embryonic stem (mES) cells [83]. This study used a cell trapping system and
genetic approaches to create an insulin secreting cell clone. Although the cells were able
to reverse hyperglycemia upon implantation in mice, the hyperglycemia was reversed in
12 weeks suggesting that the cells either stopped making insulin or dedifferentiated. A
study by Hori et al. showed that the use of growth inhibitors such as LY294002 and
Wortmannin promoted differentiation of mES cells into IPCs [85]. They used a simple
protocol in contrast to the complex genetic approaches employed previously, and the
cells maintained their insulin producing
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status after engraftment in mice. However, widespread teratoma formation was observed
in the treated mice within three weeks of implantation.
Lumelsky et al. demonstrated derivation of insulin producing cells (IPCs) from a
highly enriched nestin positive cell population [84]. It has been shown that nestin positive
cells give rise to both neuronal cells [173] and beta cells [174]. This method used a serum
free medium with insulin, transferrin, selenium and fibronectin (ITSFn), which promotes
cell death of most types of cells excluding the nestin positive cells, thus enriching their
population [175]. The study resulted in IPCs that were glucose responsive and provided
the first evidence of the IPCs self-assembling into islet like structures in vivo. But the
IPCs transplanted subcutaneously in the shoulder of diabetic mice were not able to
correct hyperglycemia consistently, as the insulin produced by these cells was about 50
times lower per cell compared to a native islet cell [84]. Recent evidence suggested that
these IPCs may not have produced insulin endogenously but had absorbed insulin from
the culture medium [77, 87].
In contrast to a study by Lumeskly et al., Blyszczuk et al. showed that nestin
selection was not necessary to produce IPCs from mES cells. However, their
differentiated IPCs showed a partial CK19 expression which is highly expressed in
pancreatic ductal cells [176, 177] but not in functional islets [178]. The IPCs also
exhibited relatively low levels of insulin, suggesting that they were immature [172]. In
addition, upon transplantation of the graft in mice, there was a delay of two weeks before
the hyperglycemia was reversed; suggesting that further in vivo maturation step was
necessary for mES derived IPCs [172].
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Assady et al., demonstrated derivation of IPCs from human embryonic stem
(hES) cells [76]. The differentiated cells expressed beta cell markers such as glut-1, glut2, insulin and glucokinase, but the glucose responsiveness of the cells was not tested.
D’Amour et al. used a five step protocol that mimicked the in vivo pancreatic
organogenesis by directing hES cells into sequential developmental stages. These stages
led the cells to progress from definitive endoderm stage into mature insulin producing
cells [94]. However, this protocol resulted in cells that co-expressed more than one
hormone including glucagon, somatostatin and PP. In addition, these cells failed to
respond to glucose stimulation. To improve the maturation of these cells, Kroon et al.,
transplanted endocrine precursor cells derived from hES cells into mice for further in vivo
maturation [95]. The mice were able to maintain normal glucose levels after >100 days of
transplantation. Upon graft extraction, it was found that the hES derived IPCs had insulin
secretory properties similar to that of engrafted adult human islets [95].
Despite all the recent advancements, low differentiation efficiency still remains a
challenge. The current yield of IPC differentiated from hES cells is 0.8-7.3% [94, 168].
To improve the differentiation efficiency, studies have explored the effects of growth
factors such as retinoic acid (RA) and activins. RA is a strong teratogen and shown to
induce ES cells into different cell types including neuronal [98], cardiac [99] and smooth
muscle cell [100] depending on the time and concentration of exposure. A previous
study reported that the addition of RA did not affect the differentiation efficiency [10].
However, when RA was used in combination with activin A, increase in both pancreatic
and neuronal population from mES cells was observed [73]. Moreover, the use of
conditioned medium from embryonic pancreatic buds [179], resulted in significant
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upregulation of certain genes involved in beta cell development. A summary of various
factors used in IPC differentiation is presented in Table 2.2.
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Glucose, poly-L-ornithine, FN, apo-transferin,
L-glutamine, RA, nicotinamide, insulin-like
growth factor, matrigel, FGFR2IIIb, HGF, EGF

Elghazi et al. (2002); Feng et al. (2005); Gao et al.
(2003); Hori et al. (2005); Suzuki et al. (2002)

bFGF

Basic fibroblast growth
factor

Nicotinamide

EGF

Endothelial growth factor

Promotes formation of fetal porcine islet-like cell
clusters and increases the rates of proinsulin

Promotes the proliferation of nestin-positive cells

Cho et al. (2008); Tang et al. (2004)

Kelly et al. (2005); Schwindt et al. (2009);
Tureyen et al. (2005)

Kelly et al. (2005); Schwindt et al. (2009);
Tureyen et al. (2005)

Wang et al. (2004)

Promotes b-cell proliferation and regeneration,
regulates the pancreatic islet differentiation

HGF

Hepatocyte growth factor

Promotes the proliferation of nestin-positive cells

Li et al. (2004); Shi et al. (2005); Sun et al.
(2007)

Regulates neogenesis of b cells in vivo

Bai et al. (2005); Hardikar et al. (2002)

Activin-A

BTC

Betacellulin

The most potent stimulator of oral glucose-induced
insulin secretion, GLP-1 is released in response to
meal intake and is rapidly metabolized and
inactivated by dipeptidyl-peptidase-4

References

Cho et al. (2008); Li et al. (2004); Oh et al.
(2011); Shi et al. (2005); Sun et al. (2007)

GLP-1

Glucagon like peptide

Function

Plays an important role in regulating growth and
differentiation of pancreatic b cells

Abbreviation

Extrinsic factors

Table 3 Extrinsic factors promoting b-cell proliferation and differentiation

Source: [5]

DAPT N-[N-(3,5-difluorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl ester, RA retinoic acid, BTC-d4 betacellulin-delta4, FN fibronectin, LAM
laminin, HGF hepatocyte growth factor, EGF epidermal growth factor

Progenitor cells

Timper et al. (2006)

Glucose, nicotinamide, activin-A, exendin-4,
HGF, pentagastrin, BTC

Adipose tissue-derived MSCs

Hisanaga et al. (2008); Lin et al. (2010); Sun et al.
(2007)
Chao et al. (2008); Gao et al. (2008)

Activin-A, conophyline, BTC-d4, BTC,
nicotinamide, L-glutamine, FN, LAM, HGF,
extendin-4

Umbilical cord blood derived MSCs Glucose, RA, nicotinamide, epidermal growth
factor, exendin-4, B27

BM-MSCs

B27, nicotinamide, insulin, transferin, selenium, FN, Bai et al. (2005); Boyd et al. (2008); Cho et al.
exendin-4, LY294002, activin-A, LAM, RA,
(2008); D’Amour et al. (2006); Hori et al. (2002);
GLP-1, Nodal, IDE1, IDE2, FGF-10,
Kroon et al. (2008); Shi et al. (2005)
cyclopamine, extendin-4, DAPT

Embryonic stem cells

References

151

Differentiation factors

Type

Cell type

Table 2 Differentiation factors and cell types

Arch.
Immunol.
Ther. Exp. (2013)
61:149–158
Table
2.1 Differentiation
Factors
and Cell
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Glucose, poly-L-ornithine, FN, apo-transferin,
L-glutamine, RA, nicotinamide, insulin-like
growth factor, matrigel, FGFR2IIIb, HGF, EGF

Progenitor cells

GLP-1

BTC

Glucagon like peptide

Betacellulin

References

Wang et al. (2004)

Promotes b-cell proliferation and regeneration,
regulates the pancreatic islet differentiation
Promotes the proliferation of nestin-positive cells
Promotes the proliferation of nestin-positive cells

Hepatocyte growth factor HGF

Endothelial growth factor EGF

Basic fibroblast growth
factor

Lin et al. (2010)
Degn et al. (2004)

Affects b cells differentiation, proliferation, and
insulin secretion
Promotes growth and maturation of b cells

FN

Fibronectin

mass of the blastocyst, an early stage embryo. ESCs
demonstrate the capacity for differentiation into cells of all
three primary germ layers (ectoderm, mesoderm and
endoderm) (Wobus and Boheler 2005). Given this capacity
ESCs can differentiate into any desired cell types, including b cells. Another advantage of ESCs is unlimited self-

Source: [5]

challenge, because it requires inhibition of the formation of
unwanted cell fates. Another limitation of undifferentiated
ESCs is potency of post-transplantation teratoma formation. More recently, it has been shown that transplantation
of differentiated ESCs also lead to teratoma formation
(Boyd et al. 2008). Moreover, using human ESCs for this

Lin et al. (2010)

Affects b cells differentiation, proliferation, and
insulin secretion

LAM

Laminin

Extendin 4

Chen et al. (2004)

Increases the potency of nicotinamide

b-mercaptoethanol

Cho et al. (2008); Tang et al. (2004)

Promotes formation of fetal porcine islet-like cell
clusters and increases the rates of proinsulin
biosynthesis in these clusters

Kelly et al. (2005); Schwindt et al. (2009);
Tureyen et al. (2005)

Nicotinamide

bFGF

Li et al. (2004); Shi et al. (2005); Sun et al.
(2007)

Regulates neogenesis of b cells in vivo

Activin-A

Kelly et al. (2005); Schwindt et al. (2009);
Tureyen et al. (2005)

Cho et al. (2008); Li et al. (2004); Oh et al.
(2011); Shi et al. (2005); Sun et al. (2007)

Plays an important role in regulating growth and
differentiation of pancreatic b cells

The most potent stimulator of oral glucose-induced Bai et al. (2005); Hardikar et al. (2002)
insulin secretion, GLP-1 is released in response to
meal intake and is rapidly metabolized and
inactivated by dipeptidyl-peptidase-4

Abbreviation Function

Extrinsic factors

Table 2.2 Extrinsic Factors Promoting Beta Cell Differentiation
and3 Proliferation
Table
Extrinsic factors promoting b-cell proliferation and differentiation

DAPT N-[N-(3,5-difluorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl ester, RA retinoic acid, BTC-d4 betacellulin-delta4, FN fibronectin, LAM
laminin, HGF hepatocyte growth factor, EGF epidermal growth factor

Elghazi et al. (2002); Feng et al. (2005); Gao et al.
(2003); Hori et al. (2005); Suzuki et al. (2002)

Timper et al. (2006)

Glucose, nicotinamide, activin-A, exendin-4,
HGF, pentagastrin, BTC

Adipose tissue-derived MSCs

Hisanaga et al. (2008); Lin et al. (2010); Sun et al.
(2007)
Chao et al. (2008); Gao et al. (2008)

Activin-A, conophyline, BTC-d4, BTC,
nicotinamide, L-glutamine, FN, LAM, HGF,
extendin-4

Umbilical cord blood derived MSCs Glucose, RA, nicotinamide, epidermal growth
factor, exendin-4, B27

BM-MSCs

Another challenge is to obtain fully functional insulin producing cells. Most
studies using pluripotent stem cells have reported that the differentiated cells were either
not glucose responsive [76, 84, 94] or required additional in vivo maturation steps [95,
180]. Immature cells also typically co-express multiple hormones and are not glucose
sensitive [94]. On the other hand, mature beta cells are defined by a switch from MafB+
MafA− to MafB− MafA+ status in their gene expression [181]. This switch occurs in cells
that already express Nkx6.1 and is preceded by an increase in Pdx1 expression [94]. It is
of paramount importance to produce a glucose sensitive IPC in in vitro conditions so that
the insulin secretion kinetics of these cells can be studied in detail before they are utilized
for therapeutic transplantation.
In this study, a previously published protocol [73] was used to derive insulinproducing cells from mouse embryonic stem cells. This protocol involves formation of
embryoid bodies (EBs), spontaneous differentiation of EBs into ectodermal, mesodermal
and endodermal lineages and differentiation into C-peptide and insulin producing cells.
The differentiation into multilineage progenitors, including endoderm progenitor cells, is
supported by a basic culture medium, followed by differentiation induction into the
pancreatic lineage by insulin, nicotinamide and laminin supplemented medium.

2.2 Materials and Methods
2.2.1 Mouse Embryonic Stem (mES) Cell Culture
MES cells (a generous gift from Dr. Qyang) were cultured on a layer of mouse
embryonic fibroblasts (MEF) in high glucose DMEM supplemented with 15% knockout
serum, 1% L-Glutamine, 1% sodium pyruvate, 1% non essential amino acids and 1%
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penicillin-streptomycin, β- mercaptoethanol and Leukemia inhibitory factor (LIF).
Colonies were passaged every 2-3 days onto freshly plated MEF cell layers. Medium was
exchanged everyday.
2.2.2. Derivation of Insulin Producing Cells (IPCs) from mES Cells
MES cells were used to derive IPCs using a previously established protocol [73]. To
induce differentiation into pancreatic beta cells, mES cells were differentiated by
formation of embryoid bodies (EB). A cell suspension made with a total of 0.3 million
cells in 10 ml of differentiation medium #1 (IMDM medium supplemented with 20%
FBS, 1% L-Glutamine, 1% pencillin-streptomycin and 1-thioglycerol. Refer to Appendix
A for details) was use for making hanging drops in P100 petri dishes (USA Scientific). A
total of 8 rows of hanging drops were added in each dish to give 64 EBs/plate. After two
days of hanging drop culture, the EBs from each dish were collected in a P60 Petri dish
using differentiation medium #1 and cultured in suspension culture conditions for two
days. The EBs were then transferred into a 0.1% gelatin coated P60 tissue culture treated
dish. 4 mls of medium was added and the dishes were moved in the “8” pattern seven
times for even distribution of EBs in the dish. The dishes were incubated and were not
disturbed for at least 36 hours to facilitate proper attachment of the EBs to the surface of
the dish. Medium was exchanged every 2-3 days.
After 9 days of culture, the cells on the dishes were digested and replated. To
digest the cells, the medium was first aspirated, and the spread out cells were washed 2X
with PBS. Then 0.5% trypsin and 0.25% trypsin were added in 1:3 ratio to the cells and
incubated for 3 min at 37 °C. Trypsin was gently removed and the cells were detached
using a cell scraper (USA Scientific). 4 mls of differentiation medium #2 (Refer to
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Appendix A for details) supplemented with 10% FBS was added to each dish containing
trypsinized cells. The cells were mixed well by pipetting and the resulting cell suspension
contained single cells and cell aggregates. 428 µl of cell suspension was added to each
well of a 6 well plate previously coated with 0.01% poly-ornithine & 1 µg/ml laminin.
Additional 2 ml of medium was added and the plates were incubated for 18 days. The
dishes were moved vertically and horizontally seven times to distribute the cells evenly
throughout the wells. The medium was switched to serum free conditions the day after
digestion. Medium was exchanged every 2-3 days. A schematic of the protocol is shown
in Fig. 2.1.
2.2.3 Dithizone Staining
Dithizone (DTZ) is a zinc chelating agent and has been shown to selectively stain the
insulin producing cells crimson [182]. DTZ stock solution was prepared by dissolving 50
mg of dithizone (Sigma) powder in 5mls of DMSO (Sigma). After vortexing, the mixture
was aliquoted in 200 µl tubes and stored at -20 °C for long term use. For staining the
cells, 10 µl of DMSO stock solution/ml of medium was used. The solution was filtered
using a 0.2 µm syringe filter (Nalgene) and placed briefly at -20 °C for 30 seconds.
The cells were washed with Hanks balanced salt solution (HBSS) 2X prior to the
addition of DTZ staining solution. Cells were then incubated with DTZ staining solution
for 15 minutes at 37 °C. To image the cells, they were washed 3X with HBSS. The DTZ
positive cell clusters that were stained with crimson color were detected and marked at
the bottom of the plate.
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2.2.4 Immunofluorescence Studies
Cells at Day 33 of differentiation were fixed with 4% p-formaldehyde (PFA) for 2 hours
at room temperature, washed 3X with PBS and then were either stored at 4 °C till they
were ready to be used for immunofluorescence or were used directly. Fixed cells were
first blocked for 1 hour with 10% goat serum (Sigma) in PBS at room temperature. Then
the primary antibodies were added and incubated overnight at 4 °C. Primary antibodies
used were polyclonal rabbit anti FoxA2 (Abcam, 1:1000), polyclonal rabbit anti PDX1
(Abcam, 1:2000), polyclonal mouse anti insulin/Proinsulin (Abcam, 1:1000), polyclonal
rabbit anti C-peptide (Abcam, 1:1000). After multiple washes with PBS, cells were
incubated with secondary goat anti-rabbit IgG FITC (Abcam, 1:2000) or secondary goat
anti-mouse IgG Texas Red (Santa Cruz, 1:200) for 1 hour at room temperature. Cells
were mounted on a glass slide using a mounting medium with DAPI (Vectastain Lab) for
imaging.
2.2.5 Immunohistochemistry Studies
Cells were fixed with 4% PFA for 2 hours at room temperature, washed 3X with PBS and
then were either stored at 4 °C till they were ready to be used or were used directly.
Samples were first boiled for 25 min in antigen retrieval buffer (0.01M citric acid,
pH=4.4) at 95-100 °C loosely covered in foil. After allowing to cool at 20 min at room
temperature, cells were blocked for 1 hour with 10% goat serum (Sigma) in PBS at room
temperature. Polyclonal mouse anti insulin/Proinsulin (Abcam, 1:1000) was added and
incubated overnight at 4 °C on a rocker. After multiple washes with PBS, cells were
incubated with secondary goat anti-mouse IgG HRP (Santa Cruz, 1:200) for 30 min at
room temperature. Cells were then treated with the Vectastain Elite ABC reagent kit
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(Vector Labs) and Vector NovaRed substrate solution (Vector Labs) following the
manufacturers instructions. Cells were washed with DI water for 5 minutes and then
counterstained with Hematoxylin (Vector labs). The samples were allowed to dry
overnight and then mounted using a Permount mounting medium (Fisher). Images were
captured using a color camera mounted on an inverted microscope (Nikon C1Si).
2.2.6 Glucose Challenge Test
To perform a glucose challenge test, cells at the end of differentiation i.e., Day 33 were
treated separately. Cells were washed 2X with sterile warm PBS and were switched to
insulin free medium so that the insulin uptook from the medium does not contribute to
the detected insulin levels when performing an ELISA. After 24 hours the medium was
removed and the cells were washed 2X with warm PBS, and then incubated with Krebs
Ringer Bicarbonate Hepes buffer (KRBH, See Appendix for details) supplemented with
2.5mM glucose for 90 minutes. The supernatant was collected and aliquoted in 200 µl
tubes and stored at -20 °C.

The cells were then incubated with KRBH buffer

supplemented with 27.7 mM glucose for another 2 hours. The supernatant was again
collected, aliquoted in 200 µl tubes and stored at -20 °C until ready to be analyzed.
2.2.7 Insulin ELISA
An ELISA was performed on the samples using the Mouse Insulin ELISA kit (Mercodia)
as per the manufacturers instructions. The plate was read using an Emax plate reader
(Molecular devices) at 450 nm. A standard curve was drawn using the absorbance values
of the calibrators with known insulin concentration and an equation was derived, which
was used to calculate the concentration of insulin in the samples. A high positive control
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(Mercodia) was used to verify experimental values. All samples were prepared in
duplicates.
2.2.8 IPC Yield Calculation
In order to calculate the yield of IPC clusters, DTZ staining was performed as described
in Section 2.3. Once DTZ+ clusters were identified, they were manually isolated using a
sterile fine bent tip forceps. Isolated IPC clusters were collected in a 1.5 ml micro
centrifuge tube filled with FBS. Most IPC clusters were found to be closely associated
with cell sheets, and these were carefully teased apart using another pair of fine tip
forceps or scissors. After all the IPCs were collected, FBS was removed and the IPCs
were washed with PBS 3X to remove traces of serum. IPC clusters were then incubated
with 0.25% trypsin for 3 min and pipetted multiple times to facilitate the dissociation of
the clusters into single cells. Cells were suspended in trypan blue solution and the cell
counting was performed using a hemacytometer. The yield of IPC was calculated as the
DTZ+ cells/total number of cells.
2.2.9 RNA Isolation
Frozen IPC cluster pellet were used for RNA isolation using the RNeasy mini kit
(Qiagen). Once the pellets were thawed out, RLT buffer supplemented with 10% of 2beta mercaptoethanol was added directly to the cell pellet and vortexed to mix well. The
lysate was passed 8-10 times through a 20 G needle attached to RNase free syringe
(Fisher) to homogenize the samples. The samples were centrifuged at 14,000 rpm for 3
min in a microcentrifuge (Eppendorf) and the supernatant was transferred to a new
RNase free tube. One volume of 70% ethanol was added to the lysate and mixed well by
pipetting. Up to 700 µl of the sample was added to the spin column placed in a 2 ml
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collection tube and centrifuged at 10,000 rpm for 30 sec. The flow-through was discarded
and 700 µl of RW1 buffer was added to the spin column and centrifuged at 10,000 rpm
for 30 sec. The flow through was discarded once again and 500 µl of RPE buffer was
added to the spin column and centrifuged at 10,000 rpm for 30 sec. The flow-through was
discarded at the end and the procedure was repeated with centrifugation at 10,000 rpm for
2 min. The flow through and the collection tube were both discarded and the spin column
was placed in a fresh collection tube. The empty spin column was centrifuged at 14,000
rpm for 1min to remove the final traces of impurities. The collection tube was discarded
after this step and the spin column was placed in an RNase free 1.5 ml collection tube. 35
µl of RNase free water was added directly at the center of the spin column in one swift
stroke. The membrane appeared to become completely wet by this addition of water. The
cap of the tube was cut off and the spin column was centrifuged at 10,000 rpm for 1 min
to elute the RNA. The isolated RNA was stored on ice for use within 2 hours or kept at 80 °C for long term storage.
2.2.10 RNA Quantification
RNA quantification was performed using a Nanodrop spectrophotometer (Nanodrop).
First the instrument was blanked using RNase free water. 1 µl of the RNA sample was
then placed on the measurement area and the A260/280 ratio was recorded along with the
concentration in ng/µl. A260/280 is the ratio of absorbance of the RNA sample at 260 nm to
280 nm. A260/280 value of 1.8-2 is acceptable quality of RNA. A260/280 value of 2 is
characteristic of pure RNA.
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2.2.11 Primer Design
Primers were designed using the OligoperfectTM designer by Life technologies. The
reference sequence of the species and gene of interest were obtained from RefSeq (NCBI
reference sequence). All the primers were designed for detection only. The primers with
Guanine – Cytosine (GC) content of approximately 50% and Tm close to 55 °C were
selected. Once the primers were selected, the 5’ sequence of the forward and reverse
primer were added in the Oligoanalyzer software 3.1 (Intergrated DNA technologies).
Self dimerization and hairpin formation were assessed at the temperature range of interest
i.e., 50 °C- 60 °C. The primer sequences were then tested using the Primer blast software
(NCBI) to check homology with other genes/species. Primers were purchased from
Sigma Aldrich and were diluted to 20 µM concentration using RNase free water and
stored at -80 °C before use.
2.2.12 RT PCR Studies
cDNA synthesis was done using a high capacity cDNA reverse transcription kit (Life
Technologies). All the kit components were thawed over ice and the cDNA synthesis was
done as per the manufacturers instructions. The reaction mixture contained purified RNA,
10X reverse transcription buffer, 25X 100 mM dNTP mix, 10X Reverse transcription
random primers, multiscribe reverse transcriptase and nuclease free water. The reaction
conditions were 25 °C for 10 min, 37 °C for 120 min, 85 °C for 5 min and a final hold at
4 °C. 400 ng of RNA was used per reaction and the cDNA synthesis was performed in a
T100 thermal cycler (Biorad). The cDNA produced was either stored at 4 °C for shortterm storage or at -20 °C for long-term storage. PCR was performed using iTaq DNA
polymerase kit (BioRad). All the kit components were thawed over ice. The reaction
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mixture included 10X iTaq buffer, 50mM MgCl2, 10mM dNTP mix, iTaq DNA
polymerase, forward and reverse primers, RNase free water and cDNA. About 10 ng
cDNA was used per reaction. All samples were run in triplicates and included a no
template control. The reaction was run in a T100 thermal cycler (Biorad) with the
following conditions: (i) 95 °C for 3 min (ii) 40 repeats of 95 °C for 30 sec, 55 °C for 30
sec and 72 °C for 30 sec (iii) 72 °C for 10 min and (iv) 4 °C hold. All reagents were
purchased from BioRad unless otherwise stated.
For RT-PCR, 10 ng of cDNA was added per well of a clear 96-well PCR plate
(Life Technologies). A mastermix containing Sso Advanced SybrGreen supermix
(BioRad), 20 µM forward primer, 20 µM reverse primer and RNase free water was added
to each well. All samples were run in duplicates. Once all the reagents were added, the
plate was covered with a clear adhesive film. The plate frame was tapped gently to mix
the contents and then placed inside a plate spinner to remove the bubbles. The reaction
was run in an Applied biosystems 7300 (Life technologies) with the following conditions:
(i) 30 sec at 95 °C (ii) 40 repeats of 95 °C for 30 sec and 60 °C for 30 sec.
2.2.13 DNA Gel Electrophoresis
One percent agarose solution was made using PCR grade agarose dissolved in Tris
acetate EDTA (TAE) buffer. The solution was heated in a microwave for 3 min to ensure
that the agarose was completely dissolved. 10 µl of Ethidium bromide was added per 100
mls of the 1% agarose solution. At this point, the solution turned from clear white to clear
pink. The solution was poured into a casting tray covering about 75% of the comb teeth
height and then placed in the fridge for 10 min. Once the gel appeared firm to touch by
hand, the casting tray was lifted and connected on to the electrophoresis setup. TAE
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buffer was added to fill the gel run chamber and the combs were carefully removed. 8 µl
of 1kB+ DNA ladder (Life Technologies) was added to the first lane of the gel. 2 µl of
nucleic acid sample loading buffer (5X, BioRad) was added to 10 µl of PCR sample and
loaded onto the wells. The electrophoresis was performed at 100 V till all the bands
separated. When the lower dye front was about half way down, the run was paused and
the gel was lifted manually, placed inside the UV tray of the Chemi doc XRS (BioRad)
and imaged using the UV transiluminator. Image Lab software (BioRad) was used to
capture and process the image. All reagents were purchased from BioRad unless
otherwise stated.
2.2.14 Statistical Analysis
Results are presented as mean± standard deviation to account for sample size. A one-way
paired student T-test was used for comparing statistical significance between two data
sets and a one-way ANOVA test was used when more than two data sets were involved.
Statistical significance was accepted for p<0.05.
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2.3 Results
2.3.1 Differentiation of Insulin Producing Cells (IPCs) from mES Cells

Figure 2.1 Schematic of the IPC Differentiation Protocol. Undifferentiated mES cells
were formed into EBs using a hanging drop method. The resulting EBs were collected
and plated on a gelatin coated dish on day 7. The spread out cells were digested and
were re-plated on a poly-ornithine and laminin coated dish on day 16. The definitive
endoderm marker, FoxA2 was detected on Day 21, while C-peptide and Insulin,
pancreatic progenitor marker PDX1 and beta cell marker, respectively, were detected
on Day 23 and 33 of differentiation.

MES cells were used to derive insulin producing cells by following a previously
established protocol [73]. Figure 2.1 shows a schematic of the differentiation protocol
used in this study. This differentiation protocol yielded IPC (insulin producing cells)
clusters that have size range of 300-400 µm in diameter. The size of these clusters was
much larger compared to native mouse islets which are 50-200 µm in size [2]. Other cell
types including endothelial cells often accompanied the clusters.
During the entire differentiation period, cells were examined at various stages to
check for specific markers. Figure 2.2 shows a western blot analysis confirming the
expression of definitive endoderm (DE) markers such as FoxA2 and Sox17 as early as
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Day 6, which corresponds to when the EBs were in suspension culture conditions. The
expression of these markers continued till the end of differentiation i.e., Day 33. This is
in agreement with previous studies that have shown that FoxA2 expression is found in
developing pancreas and continues in adulthood, mainly in islets of Langerhans, ductal
cells and acinar cells [183].

Figure 2.2 Expression of Definitive Endoderm by Differentiating MES Cells. EBs
formed by a hanging drop method and subsequent the suspension culture showed
expression of definitive endoderm markers such as FoxA2 and Sox17 as early as Day
6 of culture and continued expression till Day 33.
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Immunofluorescence studies were performed to detect important markers along
the beta cell development pathway. Figure. 2.3A shows the expression of FoxA2, which
started as early as Day 6. The pancreatic progenitor marker, PDX1, was detected on Day
23 of differentiation as shown in Figure. 2.3B. At the end of the differentiation protocol
i.e., Day 33, the presence of C-peptide was detected, as demonstrated in Figure. 2.3C. An
immunohistological

analysis

showed

that

the

cells

were

also

positive

for

Insulin/Proinsulin expression at Day 33 as shown in Figure. 2.3D.

Figure 2.3 Expression of Pancreatic Specific Markers by IPC Clusters.
Immunofluorescence images showing cells positive for (A) FoxA2 confirming
endodermal lineage at D21, (B) Pdx1 confirming pancreatic progenitor cells at D23,
and (C) C-peptide at D33 of differentiation. (D) A representative
immunohistochemistry image at Day 33 shows the presence of insulin/pro-insulin.
Scale bar: 100 µm.
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2.3.2 Yield of IPC from mES Cell Differentiation

Figure 2.4 Dithizone (DTZ) Staining. A DTZ positive cluster at D33 of differentiation
is shown on the left with crimson color cluster whereas an unstained negative cluster
is shown on the right for comparison. Scale bar: 500 µm.

To determine the differentiation yield, differentiated cells were stained using a Dithizone
(DTZ) staining method at Day 33 of differentiation [182]. Figure. 2.4(A) shows a DTZ+
IPC cluster stained crimson and an unstained cluster for comparison (Figure. 2.4B).
Figure. 2.5 shows the yield of DTZ+ IPC clusters from individual batches. On average,
six DTZ positive cell clusters were found in a 9.5 cm2 surface area (area corresponding to
one well of a 6-well plate) as shown in Figure. 2.6A. This corresponds to approximately
5.76% of the total number of cells present in the same size dishes (Figure. 2.6B).
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Figure 2.5 Yield of DTZ+ Cell Clusters. A graphical representation of the yield of
individual batches is shown (n=27, Mean±SD).

Figure 2.6 Differentiation Efficiency of IPC Clusters from mESCs. (A) The graph
shows the average number of IPC clusters obtained from 9.5 cm2 area, which
corresponds to either a P35 dish or a well of a 6 well plate (n=27). (B) The graph
compares the average number of IPCs obtained/9.5 cm2 to the total number of cells
present in the same size dishes (n=27, p<0.05).
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2.3.3 Factors Effecting Differentiation Yield
During differentiation process, digestion of EBs yielded a mix of single cells and cell
aggregates. The differentiation process requires these single cells and cell aggregates to
be plated for additional 18 days until the completion of differentiation. To determine
whether the presence of cell aggregates in the culture affects the overall differentiation
efficiency, three different conditions were prepared. Differentiation cultures were
prepared either with no aggregates, with no aggregates but with additional cells to
maintain similar cell density or aggregates and single cells mix. Culture with a mix of
single cells and cell aggregates was used as a control. Our results show that the yields
were lower in the test samples and no significant differences were observed when
compared to control samples as shown in Figure 2.7.
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Figure 2.7 Factors Affecting Differentiation Efficiency – Presence of Cell Aggregates
(n=10).

In addition, when the differentiation culture was extended for an additional 7 days
beyond 33 days of culture, a significant increase in the number of DTZ+ cell clusters was
observed indicating that the culture duration was a critical factor in determining IPC
cluster yield (Fig. 2.8)
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Figure 2.8 Factors Affecting Differentiation Efficiency – Culture Duration. A
significant increase in the average number of IPC clusters was observed in longer
culture (Mean ± SD, p< 0.05).

2.3.4 Glucose Responsiveness of Differentiated IPCs
An insulin ELISA was performed to quantify the amount of insulin produced by
differentiated IPCs as well as to determine whether the IPCs were glucose responsive.
Our ELISA results demonstrated that the IPC secrete significantly higher insulin when
exposed to higher glucose concentrations, indicting that they are glucose responsive as
shown in Fig. 2.9.
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Figure 2.9 Insulin ELISA Assay. An insulin ELISA followed by a glucose challenge
test demonstrated that mES derived IPCs are glucose responsive (n=6, p<0.005).

2.3.5 Pancreatic Gene Expression by Differentiated IPCs
Freshly isolated DTZ+ IPC clusters were used for RNA extraction and subsequent gene
expression analysis. PCR revealed that the insulin-positive cell clusters express beta cell
specific genetic markers such as Ins2, PDX1, Nkx6.1, Pax4, Glut2 and EphrinA5 as
shown in Figure. 2.10. GAPDH was used as a housekeeping control. Beta cell specific
markers are important genetic markers that are expressed by a mature beta cell.
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Figure 2.10 Gene Expression Analysis of IPC Clusters. IPCs expressed beta cell
specific markers such as Insulin, PDX1, Glut2, Nkx6.1, Pax4 and EphrinA5. GAPDH
was used as a housekeeping control.

2.4 Discussion
In this study, a previously established protocol was used to derive IPCs from mES cells
[73]. At the end of a 33 days long protocol, IPC clusters, identified by DTZ staining,
were successfully obtained. DTZ is known to form a chelate complex with the zinc ions
stored inside the beta cells. DTA staining is widely used for detecting endogeneous
insulin secretion by beta cells as the beta cells secrete zinc along with insulin [184, 185],
The differentiated cells express both FoxA2 and Sox17 throughout the differentiation
timeline. FoxA2 and Sox17 genes are widely known as definitive endoderm (DE)
markers [186-190]. The pancreas develops from the DE, and so the expression of these
markers suggests that the cells differentiate towards DE lineage, which is the first step in
progressing them towards a beta cell fate. Previous studies have shown that FoxA2
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expression is found in the developing pancreas and continues in adulthood, mainly in
islets of Langerhans, ductal cells and acinar cells [183]. This is consistent with our study
where the expression of FoxA2 at Day 33 of culture is detected by western analysis.
To further characterize the identity of IPCs derived from mES cells, gene
expression analysis was performed. Our mES-derived IPCs expressed beta cell specific
markers such as insulin and C-peptide demonstrating insulin production by these cells.
Both of these genes have been shown to play an important role in the beta cell
development. As beta cells are known to secrete insulin in response to a glucose stimulus,
secretion of insulin is one of the key characteristics of beta cells. However, previous
reports have shown that in in vitro cultures, dead cells can take up insulin from the
medium and thus account for a false positive [77, 87]. C-peptide, which is formed when a
proinsulin molecule cleaves to form an insulin molecule, has thus been used as a more
reliable marker for insulin producing cells. C-peptide is not present in the medium and
thus detection of C-peptide indicates endogenous insulin production by cells. Ins 2 or
Pro-insulin is the uncleaved version of Insulin. The expression of Ins 2 and C-peptide
confirms the endogenous production of insulin by mES-derived IPCs demonstrating that
these cells were functional in terms of insulin production.
Moreover, differentiated cells express PDX1 and Nkx6.1, which are important for
pancreatic development and beta cell function. PDX1 has been shown to serve as a
master regulator of β cell fate by simultaneously activating genes essential for β cell
identity and repressing those associated with α cell identity [191]. Low levels of PDX1
have been associated with beta cell death during onset of diabetes [192, 193]. Nkx6.1
gene is necessary and sufficient for expression of beta cell specific markers in

51

differentiating endocrine precursors in the embryo [194]. In vitro studies using beta cell
lines and isolated islets have also suggested that Nkx6.1 may play a role in the regulation
of glucose-stimulated insulin secretion as well as beta cell proliferation [195, 196].
Deletion of Nkx6.1 causes rapid-onset diabetes due to defects in insulin biosynthesis and
secretion followed by ectopic activation of delta cell genes in beta cells [197]. Nkx6.1
gene is therefore important in maintaining the phenotype and genotype of beta cells.
Pax4 is known to be a key regulator of beta cell mass [198]. Inactivation of Pax4
results in the absence of mature β and δ cells in the pancreas but increases the number of
alpha cells, suggesting that the early expression of Pax4 is essential for the differentiation
of the β and δ cell lineages [199]. The expression of Pax4 by the culture indicates the
development of endocrine progenitor cells in the differentiation culture. It also suggests
the possibility of the presence of δ cells in the cell culture.
Moreover, it was demonstrated that our IPCs also express GLUT2 and EphrinA5.
Glucose transporter 2 (GLUT2) also known as solute carrier family 2 (facilitated glucose
transporter), member 2 (SLC2A2) is a transmembrane carrier protein, that enables
glucose movement across cell membranes unclear [200]. GLUT2 is known to be the
principal glucose transporter in beta cells in rodent islets, but is not the principal glucose
transporter in human islets [201]. GLUT2 mediates the bidirectional transport of glucose
in beta cells and forms part of the glucose sensing mechanism of the beta cell [200] and
thus plays an important role in making beta cells glucose responsive. The differentiating
cells also expressed GLUT2. EphrinA5 is a ligand for Eph receptor proteins and is
localized on the plasma membrane and thus needs direct cell-to-cell contact for activation
[202-204]. It is important in beta cell-to-cell communication and also in glucose
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stimulated insulin secretion [205]. The expression of these genes indicates that the
differentiated IPCs exhibit beta cell specific markers.
As one of the important characteristics of pancreatic beta cells is their ability to
regulate insulin secretion depending on the level of glucose they are exposed to,
functional characterization of differentiated IPCs was performed. Our differentiated IPCs
secrete insulin and upregulated their insulin secretion in response to higher glucose
conditions. The insulin secretion from 10 islets at 2 mM and 20 mM has been reported to
be 1 ng/ml/hr and 2 ng/ml/hr, respectively [206]. This number can vary depending upon
the age and sex of the animal and also the methods used for isolating the islets and
duration of islet culture after isolation before the glucose challenge was performed. As
the differentiating IPCs were significantly bigger in size than the islets, it is difficult to
compare the results.

Fig. 2.11 Biphasic Insulin Secretion Response to Glucose Stimuli. Adopted from
Rorsman et al.
Source: [4]

n coupling of pancreatic β-cells. SUR, sulphonylurea receptor; KATP, ATP-regulated K+ channel. B: glucose-stimulated electrical
n an intact islet when glucose concentration was increased from 5 to 10 mM as indicated by staircase above membrane potential
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ced insulin secretion. Glucose was elevated to 11 mM as indicated by horizontal bar. Note presence of a rapid first phase (lasting
phase. Data redrawn from Ref. 10. D: possible interpretation of release pattern. Whereas first phase insulin secretion can be enviseadily releasable pool of granules (RRP), second phase is due to release of granules that may be located further away from release
on of granules from reserve pool into RRP involves one or several ATP-dependent reactions (7, 11).

A normal mouse has an average blood glucose of around 80 mg/dl [207], which is
similar to humans. When this level increases for example, due to diet intake, insulin is
secreted. Glucose stimulated insulin secretion in mice and rat islets is biphasic in nature
and consists of a transient first phase followed by a sustained second phase [208-211] as
shown in Figure. 2.11. However, in in vitro conditions only the first phase of the response
is seen [4].
While IPCs were obtained in this study, the differentiation efficiency however,
was rather low, yielding approximately 5.76% of insulin-producing cells from the entire
cell population. As differentiation of beta cells is a complex process, multiple factors can
affect the efficiency. Our results from examining several factors affecting the yield of
differentiation suggest that presence or absence of cell aggregates after digestion was not
a critical factor in determining the differentiation yield. However, the cell density for replating was found to be a critical determinant for the IPC yield. Further studies will be
needed to confirm whether a lower cell density can result in higher differentiation yield
and vice versa. In addition, the effects of Exendin-4, a potent agonist of GLP-1 [212] and
activin A can be explored as they are shown to promote islet differentiation, maturation
and increased insulin content in various cell lines [213, 214].
It was observed that an increase in duration of culture period resulted in a
significant increase in the differentiation yield. This suggests that the cells continue to
differentiate beyond Day 33, which is the end point of current protocol used. Further
studies are needed to determine whether a further increase of the culture duration will
result in an even higher yield of IPCs and whether the glucose responsiveness of the IPCs
is also affected.
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The presented study followed a previously described protocol [73] with just one
minor change. The suspension culture was done for two days instead of three days. It was
noticed that at the end of three days, the EBs did not stay in suspension. Instead they
attached to the petri dish and started spreading out. In order to transfer them to the gelatin
coated dish they had to be lightly scraped off the surface of the Petri dish. As this might
cause mechanical damage to the cells, the suspension culture was terminated after two
days when the EBs were still in suspension. The exact effect of this change on the final
outcome is yet unclear.
In conclusion, this study presents the differentiation and characterization of IPCs
obtained from mES cells. Although the protocol has been previously reported [73], the
study presents approaches to improve the yield of IPC clusters. It was found that an
increase in culture duration for up to seven days resulted in a higher yield of IPCs, while
excluding the cell aggregates and doubling the cell density after re-plating resulted in a
decrease of yield. Further experiments are required to study the specific effects of cell
density on the IPC differentiation yield.
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CHAPTER 3
DEVELOPMENT OF IPC CLUSTER EMBEDDED 3D TISSUES

3.1 Introduction
Islets of Langerhans are micro-organs located in the pancreas and composed of at least
four types of endocrine cells. The α and βcells are the most abundant and also the most
important ones as they secrete the hormones glucagon and insulin, which are crucial for
maintaining glucose homeostasis. It is generally accepted that endocrine cells in rodents
are not randomly distributed into islets, but are arranged in specific patterns. β cells
compose the core of the islets and the non-β cells, including α, δ and pancreatic
polypeptide (PP) cells, form the mantle region [46-50]. This unique architecture appears
to have important functional implications [46]. In several murine models in which insulin
secretion is decreased, normal organization of islet cells was found to be perturbed [215]
and β cells were found intermingled with non β cells.
In addition, in vitro experiments showed that homologous contacts between rat β
cells improved their function, as compared to heterologous contacts between β and non β
cells that had no effect [216]. This observation suggests that a core-mantle segregation of
islet cells is useful in favoring homologous contacts between β cells, which in turn
improves insulin secretion. The characteristic islet architecture may also serve to
facilitate interactions among the different islet hormones via interstitial or vascular routes
[47, 217]. It has also been shown that the proportion of islet β cells is lower in humans
compared with rodents [51-53] and that the various endocrine cell types are dispersed

56

throughout the human islets [51, 54]. Figure 3.1 shows a schematic representation of rat
and human islets.

Figure 3.1 Islet Architecture in Rodents and Humans. The above schematic shows the
distribution of various cell types in rodents and human islets.
Source: [8].

Currently, 2D cultures are the most common method of culturing islets in vitro.
However, 2D culture systems do not provide the much needed ECM support that is
available to islets in vivo which is important in mediating cell adhesion, providing
structural support and activating intracellular chemical signaling pathways [118, 218220]. It has been shown that culturing islets as monolayers in a 2D culture system
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disrupts their characteristic arrangement and hence negatively impacts function and
survival of the cells [221]. In the absence of this crucial microenvironment, cells either do
not mimic their physiological phenotype or many times differentiated cells fail to
maintain their functions over longer periods of time. A study by London et al. showed
that only ~56% of the islets survive after a 48 hour culture period in 2D conditions [222].
These studies suggest that 3D culture models that closely mimic physiological
environment may be necessary to promote optimum survival and function of the islets in
in vitro culture conditions.
In fact, previous studies have demonstrated that the use of biomaterials may
enhance islet function by providing a three-dimensional cellular support and delivering
proteins, growth factors, and immunosuppressive agents [223, 224]. A study by
Montesano et al. showed that when dissociated islets were embedded inside 3D collagen
gels, not only did the collagen environment provide the necessary permissive
environment for the heterozygous cells to reform the islet like spherical morphology, but
also the different cells re-assembled mimicking their topographical location [225, 226].
Another study by Zhang et al., demonstrated that culturing human islets in 3D scaffolds
reduced the formation of the toxic islet amyloid, which is known to be a pathological
characteristics of diabetes type II [227].
Moreover, a previous study showed improvement in viability and insulin
secretion profile of human islets cultured in 3D agarose gels compared to that of islets
cultured in 2D condition [129]. Various other studies using collagen and other ECM
materials to encapsulate islet cells have shown improved functionality, insulin secretion,
and higher expression of pancreatic specific genes of beta cells [130, 221, 228]. Nagata et
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al. cultured islets in a hydrogel of collagen type I mixed with collagen type III, type IV
and laminin. They found that all the mixtures suppressed cell death effectively [116].
These studies suggest that a 3D system comprised of ECM proteins may be beneficial in
improving the maturation and function of insulin producing cells in in vitro.
There have been a number of studies that have highlighted the role of vascular
endothelial cells (ECs) in beta cell biology. During development, dorsal aorta has been
shown to induce budding of dorsal pancreas and expression of pancreatic specific factors
such as Pdx1, Pax4, Insulin and glucagon [145]. EC secreted factors have also been
shown to be important for beta cell proliferation, insulin gene transcription and glucose
mediated insulin release [1, 154, 156, 229, 230].
Previous studies have shown that EC derived factors are not only critical in the
regulation of beta cell growth, proliferation but also expression of beta cell specific
markers and lineage allocation during development [1, 145, 154, 156, 167, 231]. As beta
cells are unable to form a basement membrane of their own they recruit ECs to form a
basement membrane that contains laminin, collagen type IV and fibronectin [154]. These
factors are known to promote insulin gene expression and beta cell proliferation to
different extents. A host of other EC derived factors have been shown to be beneficial for
the development of beta cells. Connective tissue growth factor (CTGF), an EC secreted
factor is important in beta cell proliferation, differentiation and islet morphogenesis [156,
231]. Another vascular derived factor sphingosine-1-phosphate has been shown to
stimulate the growth of the pancreas [148]. Hepatocyte growth factor, secreted by ECs
has been shown to support beta cell proliferation. Thus, signals mediated by the ECs are
critical regulators of the beta cell development and function [163].
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Previous studies have shown evidence that isolated islets in co-culture with ECs
show better survival, integration and functionality [159, 161-164]. A study by Adame et
al. showed that co-culture of mES derived EBs with ECs led to an increased expression
of PDX1, Ngn3, Nkx6.1, Proinsulin, GLUT-2 and Pax4 [167]. This study provided
evidence that ECs enhanced the differentiation of EBs into pancreatic progenitor cells.
However, no studies have been published regarding the effects of IECs on IPC
development in in vitro conditions. As IECs form a vascular niche for the pancreatic
development [154, 165], their presence might have a positive impact on the IPC
differentiation efficiencies and in obtaining mature glucose sensing beta cells.
Recently, a study by Lau et al. showed that highly perfused islets had superior
beta cell proliferation, function and gene expression [163]. It has been shown previously
that blood flow in islets is heterogenous [232], with some islets receiving more blood
flow than others and this heterogeneity is maintained over time [233]. Interestingly,
EphrinA5 was significantly up regulated in highly perfused islets compared to islets
having lesser flow [163]. Ephrin A5, a ligand present on beta cells has been shown to
mediate glucose stimulated insulin secretion [205].
Ephrins are the ligands of Eph receptors, the largest family of tyrosine receptor
kinases [234] and have been shown to play an important role in cell cell signaling [205,
235]. Beta cells are known to communicate with each other through EphAs and EphrinAs
[205], where EphA forward signaling inhibits insulin secretion, whereas Ephrin-A
reverse signaling stimulates insulin secretion [205]. Although it was believed that
EphrinA class ligands only react with EphA receptors, a study by Himanen et al., showed
that Ephrin A5 binds EphB2 with great affinity [236]. EphB2 is a protein that is
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expressed by endothelial cells and is important during angiogenesis [237]. As ECs play
an important role in beta cell development, it will be interesting to examine such an
interaction occur in in vitro conditions, if ECs are co-cultured with IPCs.
Thus, in the presented study, mES derived IPCs were cultured in 3D collagen gel
system to characterize their function in 3D compared to a traditional 2D culture.
Optimization studies were performed to improve survival and function of the IPCs. In
order to address the diffusion limitations that 3D tissues present, perfusion flow was
applied to the 3D tissues using a previously developed perfusion flow bioreactor [238].
The study also describes the co-culture of IPCs with ECs, which were derived from mES
cells (mESC-ECs). The details of the derivation and characterization of these cells are
presented in chapter 4. The co-culture gels were cultured under static and flow conditions
for five days and were analyzed for survivability. A detailed gene expression analysis
was performed on the monoculture and co-culture gels and the expression of beta cell
specific genes were studied. The presented study reports preliminary studies in deriving a
3D tissue using stem cell derived IPCs, which can be extended further to the development
of a unique platform for improved function and maturation of IPCs in vitro.

3.2 Materials and Methods
3.2.1 Preparation of IPC Clusters for 3D Tissues
IPC clusters were differentiated from mES cells and isolated as described in Chapter 2
section 2.2. Figure 3.2 shows a simple schematic of the gel preparation process. After
being stained positive with DTZ, IPC clusters were manually handpicked using a fine
bent tip forceps from the differentiation plate. The IPC clusters were briefly stored in
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FBS in a microcentrifuge tube and then washed 3x with PBS. The typical size of
differentiated IPC clusters was 380 um, which is much larger than a mouse islet which is
approximately 150 um [2]. Thus to obtain IPC clusters with sizes that are comparable to
physiologic mouse islets, IPC clusters were manually pipetted to dissociate them into
smaller clusters. To break the clusters into smaller pieces, a 22G needle attached to a 3
ml plastic syringe (Fisher) was used.

Repeated pipetting was necessary to achieve

smaller IPC clusters. Alternatively, the clusters can be broken down by a blunt plastic
canula (Fisher) mounted on top of a 200ul pipette tip attached to a pipetteman.
Once pipetted, the IPCs in culture medium were strained using a 40µm cell
strainer (BD Falcon) to remove cell fragments and debris from the manual disturbance.
Only the IPC clusters were collected in a petri dish and then transferred into a
microcentrifuge tube. Clusters were then allowed to settle down in a conical tube for ten
minutes. Supernatant was slowly removed without disturbing the IPCs and discarded.
Collected IPCs were used for incorporation into collagen gels as described in detail in
Section 3.2.2.
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3.2.2 Preparation of Static Collagen Tissues Containing IPC Clusters

Figure 3.2 Schematic of the Gel Preparation Process. IPCs were harvested from
differentiation culture (Day 33) in a microcentrifuge tube containing FBS using a sterile
fine bent tip forceps. After 3X PBS wash, the IPC clusters were broken down manually
by passing 5-10 times through a plastic canula. The IPC suspension was then passed
through a 40 µm cell strainer to remove dead cells and debris before being suspended
inside 3D collagen gels.

Rat tail collagen type I (BD Biosciences), 10X DMEM (Sigma Aldrich) and 10X
reconstitution buffer (0.05 N NaOH with 0.16 M HEPES and 0.25 M NaHCO3) were
mixed on ice in the ratio of 80:10:10 to form collagen solution. The final concentration of
collagen was 3 mg/ml. The pH was adjusted to 7.2-7.4 by adding 1N NaOH until the
mixture appeared salmon pink in color. 24 IPC clusters were suspended in 55 µl of the
collagen solution prepared above and added to the wells of a 96 well plate. This process
is demonstrated schematically in Figure 3.2. The collagen gel solution was incubated for
30 minutes at 37 °C to allow polymerization. Once polymerized, differentiation medium
was added to collagen gel with IPC clusters and culture medium was changed every other
day.
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3.2.3 Preparation of Flow Collagen tissues Containing IPC Clusters
A custom made bioreactor set up was used for the application of flow to the collagen
tissues containing IPC clusters [238]. A flow bioreactor is capable of applying constant
perfusion to the tissues/cells housed within. The purpose of using the flow bioreactor was
to provide flow or shear mediated cues that cells receive physiologically. The effect of
flow on the tissues was studied by comparing flow collagen tissues to statically cultured
tissues.
The collagen IPC mix was pipetted onto a polyethylene terephthalate (PET)
membrane glued onto a PDMS ring placed on the inside edge of the bottom piece of the
flow bioreactor. This porous membrane supported the gel during the experiment. To
reduce the resistance to flow created by the membrane, 15-20 holes were punched into it
using a 30-gauge needle as has been previously described. After the gel was added to the
membrane, the bioreactor was placed inside a 50 ml conical tube and allowed to
polymerize for 2 hours at 37 °C. After 2 hours, the bioreactor was brought back to the
laminar flow hood where it was fully assembled. The top piece was fastened and 3-way
stopcock valves (Smith Medicals) were attached on either side of the bioreactor using
connectors (Cole Parmer). Poly tetra fluoro ethylene (PTFE) tape was wrapped around
the threads of the connectors to make the assembly leak proof. LS’13 tubing was used to
connect the bioreactor assembly with a medium reservoir. Syringe ports (Baxter) were
attached on stopcock valves and used for filling the inlet and the outlet tubing with
medium. The bioreactor was connected to a peristaltic pump (Cole Parmer) and the flow
was started at 0.5ml/min and continued for up to 5 days.
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3.2.4 Creating 3D co-culture tissues
3D collagen gels were created by a sandwich method, which contains two layers of cells
prepared in between three layers of collagen. A schematic of the process is shown in
Figure. 3.3. To form 3D collagen gels, collagen solution was prepared as described in
Section 3.2.4 and was first poured into tissue culture plates and incubated at 37°C for 30
minutes to allow polymerization before mESC-ECs suspended in MCDB complete
medium were added on top. These mESC-ECs were allowed to spread out for 4 hours. In
the meantime DTZ staining was performed on end stage beta cell differentiation plate i.e.,
Day 33 of differentiation as described in Chapter 2 Section 2.3.
The IPC clusters thus identified by DTZ staining were used for making an IPC
embedded gel. This gel was added on top of the first layer of mESC-ECs after medium
removal. The gel was allowed to polymerize for 30 minutes and then another layer of
mESC-ECs was added on top and allowed to spread out. After 4 hours, medium was
carefully removed and a final layer of cold collagen gel solution was poured on top of the
cell layer. This process yielded a collagen gel with one layer of IPC cluster embedded gel
sandwiched between two layers of mESC-ECs. The gel was cultured for 3-5 days and
medium was changed every other day.
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Figure 3.3 Schematic for Co-culture Gel Preparation. First a layer of mESC-ECs was
added on a layer of collagen, allowed to spread for 4 hours and then DTZ+ IPC
clusters were suspended inside a 0.5mm thick collagen layer that was cast directly on
top. After 30 minutes medium, a layer of mESC-ECs was added, allowed to spread out
for 4 hours before a final layer of collagen gel was added on top. The gel was cultured
for 3-5 days under static and flow conditions.

3.2.5 Live Dead Staining
Live/Dead viability/cytotoxicity assay (Invitrogen) was used to determine the viability of
IPC cells in 3D collagen monoculture and co-culture tissues. After five days in culture,
collagen tissues subjected to flow were transferred from the flow bioreactor into a 96 well
plate using sterile fine tip forceps. Static collagen tissues were processed directly in the
96 well plates where they were being cultured. Calcein AM (2 µM) and Ethidium
homodimer-1 (4 µM) were added to stain live and dead cells, respectively. Stock
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solutions were diluted as per the manufacturer’s instructions using sterile PBS. Tissues
were incubated at 37 °C for 30 minutes while being protected from light. Samples were
imaged on a glass coverslip without washing off the staining solution using an inverted
fluorescence microscope (IX81 DSU, Olympus).
3.2.6 Immunofluorescence Studies
After five days in culture, both static and flow collagen tissues were fixed with 4% PFA
overnight at room temperature. In case of flow collagen tissues, they were removed from
the bioreactor and placed in a petri dish prior to fixation. Gels were then washed 3X with
PBS and blocked for 4 hours with 10% goat serum (Sigma) in PBS at room temperature.
Primary antibodies mouse anti Insulin/Proinsulin (Abcam, 1:1000) and rabbit anti
glucagon (Santa Cruz, 1:200) were added to the samples and incubated overnight at 4 °C
on a rocker. Samples were then washed 3X with PBS on a rocker and goat anti-mouse
pAb-Rhodamine (1:2000, Abcam) and goat anti-rabbit pAb-Texas Red (Santa Cruz,
1:200) were added and incubated for 1 hr. at room temperature. Samples were washed
again with 3X PBS and counterstained with DAPI to visualize the nuclei. Samples were
imaged using a confocal fluorescent microscope (C1si, Nikon). Images were analyzed
using the EZC 1 software.
3.2.7 Glucose Challenge
After five days in culture, both monoculture and co-culture collagen tissues under static
and flow culture conditions were collected and washed 3x with PBS. Differentiation
medium prepared separately without insulin was added to the gels 24 hr. prior to the
glucose challenge. For the gels cultured under flow, they were transferred from the
bioreactors into petri dishes containing differentiation medium without insulin. After 24
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hours, samples were washed with PBS, and were incubated with solutions containing two
different concentrations of glucose consecutively. First, the tissues were incubated with
2.5mM glucose supplemented Krebs Ringer Bicarbonate Hepes (KRBH, See Appendix
for details) for 90 minutes. The supernatant was collected prior to the incubation with
higher concentration of glucose. KRBH buffer supplemented with 27.7 mM glucose was
added and the samples were incubated for additional 2 hours. Supernatants were again
collected at the end of the incubations, aliquoted in 200 µl tubes and stored at -20 °C for
performing an insulin ELISA.
3.2.8 Real time PCR studies
After five days in culture, both monoculture and co-culture collagen tissues under static
and flow culture conditions were frozen down for RNA isolation. RNA isolation and
cDNA synthesis were performed as described previously in Chapter 2, section 2.2.9 and
RT PCR studies were performed as described in Chapter 2, Section 2.12.
3.2.9 Real Time PCR Data Analysis
Real time PCR data was exported from the SDS software (Life technologies) to an Excel
sheet (Microsoft Office 2011 for Mac). The CT values were averaged for all the samples
and were normalized to GAPDH. The CT (cycle threshold) is defined as the number of
cycles required for the fluorescent signal to cross the threshold (i.e., exceed background
level) so that it can be detected [239]. Relative gene expression analysis was performed
using the Livak method or the ΔΔCT method [9]. The Livak method includes three steps:
(i) Normalizing the CT of the target gene to the reference gene (GAPDH) (ii)
Normalizing the ΔCT of the test sample to the ΔCT of the calibrator sample and (iii)
calculating the expression ratio or the fold change.
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3.2.10 Statistical Analysis
Results are presented as mean± standard deviation. A one-way paired student T-test was
used to determine the statistical significance between two data sets and a one way
ANOVA test was performed to analyze the interaction between the culture conditions.
Statistical significance was accepted for p<0.05.

3.3 Results
3.3.1 IPC Survival in 3D Collagen Tissues

Figure 3.4 Size Comparison of IPC Clusters vs. Native Mouse Islets. The average size of
differentiated IPC clusters was approximately 380 µm in diameter (n=6), whereas the
native islets are in a size range 50-250 µm [2].

IPCs were obtained by manual isolation from differentiation plates at Day 33, using a
pair of sterile bent tip forceps. It is shown that our differentiated IPC clusters were much
bigger than the size of isolated native mouse islets (Figure. 3.4). Immediately following
the isolation, IPC clusters were plated on 2D surface to first check their viability. Figure.
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3.5A shows an IPC cluster plated on a poly-ornithine and laminin coated 2D surface
immediately after isolation without any processing. Live dead staining revealed that these
clusters consisted of a mixture of living and dead cells.
As the clusters were irregularly sized and had a complex structure, additional
steps were performed to break these clusters down into smaller pieces to derive
physiologically relevant sized clusters and to minimize diffusion limitation, The IPC
clusters were subjected to manual breaking by using either a 22G needle with sharp end
or a blunt plastic cannula attached to a syringe. When these processed clusters were
embedded in 3D collagen tissues, a large number of dead cells were observed (Figure.
3.5B). While 22G needle method was successful in creating smaller clusters, this method
simultaneously resulted in massive cell death. As a comparison, the clusters that were
directly embedded in collagen tissues without physical breaking process had fewer dead
cells (Figure. 3.5C), although the size was considerably bigger than the ones in Figure.
3.5B.

Figure 3.5 Live Dead Staining of IPC Clusters. (A) Live dead staining at Day 1 shows
IPC cluster plated on poly-ornithine and laminin coated 2D surface (B) IPC clusters
were broken down by passing through a 22G needle and then used for preparing 3D
collagen tissues. (C) 3D collagen tissue with control IPC cluster that was not broken
prior to embedding. Calcein stains the living cells green and Ethidium bromide stains
the dead cells in red. Scale bar: 100 µm.

70

Figure 3.6 Comparison of Various Methods for Removing Dead Cells/debris from
IPC Clusters. Live dead staining images show the IPC clusters subjected to preplating
for (A) 15 min, (B) 30 min, (C) 60 min still consisted of dead cells. (D) The IPC
clusters passed through a cell strainer had the least number of dead cells when
compared to all the other methods (E) shows the control, non treated IPC cluster on a
2D surface. Calcein (green) stains the living cells and Ethidium bromide (red) stains
the dead cells. Scale bar: 100 µm.
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Alternatively, a small blunt plastic canula attached to a pipette tip was used to
break the clusters, in order to minimize the damage to the cells. Although this method
resulted in a reduced number of dead cells, it did not fully eliminate the presence of dead
cells. Since the presence of dead cells can affect other cells in the 3D tissue, additional
steps were taken to remove them.
Pre-plating of the cell/clusters was performed to determine whether it can be used
to separate dead cells/debris from the IPCs. Once the clusters were manually broken
down, the cell/cluster suspension was subjected to 15, 30 or 60 min pre-plating on gelatin
coated surface. Our hypothesis was that the dead cells and other debris will not attach to
the gelatin coated surface and will remain suspended in medium, while IPCs and single
living cells will attach to the surface thus separating the living and dead cell populations.
However, as demonstrated in Figure. 3.6, pre-plating for 15-60 min was ineffective in
fully separating the living cells from the dead cell populations. As most of the IPCs did
not attach even after 60 minutes, the separation was unsuccessful.
The other method was to use a cell strainer. A 40µm cell strainer was used to
collect IPC clusters with sizes 40um and bigger on the membrane while removing the
unwanted debris and dead cells. The retentate constituted of IPC clusters and was
subsequently used for preparing 3D collagen tissues. It was observed that the cell strainer
treatment resulted in the least number of dead cells carried over in the culture as shown in
Figure. 3.6D.
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3.3.2. IPC Cluster Density in a 3D Collagen Tissue
The optimal density of IPC clusters in 3D collagen tissues was determined based on the
size of the clusters and cross-sectional area of the tissue. By assuming the diameter of an
IPC cluster to be approximately 500µm, the surface area of an average IPC cluster was
calculated to be 0.196 mm2. Thus, for a well within a 96 well plate with the surface area
of 32 mm2, 163 IPC clusters were needed to cover the entire surface of the gel with IPC
clusters. Based on the limited yield of the IPC clusters from each batch of differentiation,
densities of 10% and 15% were used in our experiments. Thus, for a well of a 96 well
plate, 16 and 25 clusters for used for a 10% density gel and 15% density gel, respectively.
Figure 3.7 shows an example of 3D collagen gels with 10% and 15% density of IPCs.
15% density gels had a higher number of IPCs embedded compared to the 10% density
gels.

Figure 3.7 IPC Density in 3D Collagen Gel. (A) A collagen tissue with 10% IPC
clusters and (B) with 15% IPC clusters. Live cells are shown in green, whereas dead
cells are in red. Scale bar: 100µm.
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3.3.3 Survival of IPC Clusters in 3D Tissues Under Static and Flow Culture
Conditions
Since it is known that tissues with thickness more than 2 mm have diffusion limitations,
[240], our 3D collagen tissues were subjected to flow to improve viability of the cells
through enhanced perfusion and nutrient diffusion. The bioreactor system had a top and
bottom piece that when screwed together formed the housing for the collagen gel.
The bioreactor was connected with a medium reservoir via silicone tubings as
depicted in the schematic in Figure 3.8. A peristaltic pump was used for the constant
perfusion of medium through the collagen tissues at 0.5 ml/min flowrate. The viability of
IPC clusters in IPCs gels cultured under static and flow conditions were compared after 5
days of culture. Live dead staining on these collagen tissues showed that the cell viability
was reduced in tissues cultured under flow conditions compared to the ones under static
conditions (Figure 3.9).

Figure 3.8 Schematic of Flow Bioreactor System. The schematic shows a bioreactor
connected to the medium reservoir through tubings and a peristaltic pump. Flow rate
of 0.5 ml/min for 5 days was used in our study.
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Figure 3.9 Live dead Staining of IPC Embedded Collagen Tissues Under Static and
Flow Conditions. At day 5 the (A) statically cultured collagen tissue had fewer dead
cells compared to the (B) tissue cultured under flow conditions. Calcein (green)
stained the living cells and Ethidium bromide (red) stained the dead cells (n=6). Scale
bar: 100 µm.

3.3.4 Survivability of Whole and Dissociated IPC Cluster Gels
In order to examine whether dissociation helps to reduce cell death in our 3D flow
system, IPC clusters were dissociated using trypsin and their survival examined in 3D
collagen tissue culture. Live dead staining after 5 days revealed the dissociated IPC gels
had an improved survivability compared to whole IPC gels both in static and flow
conditions (Figure 3.10). While comparing within the dissociated IPC gels, it was found
that the static gels had higher viability of IPCs compared to that of flow gels.
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Figure 3.10 Whole and dissociated IPC Clusters in Collagen Tissues. Live dead
staining shows the (A) dissociated IPC clusters and (B) whole IPC clusters in
statically cultured collagen tissues, respectively, and (C) dissociated IPC clusters and
(D) whole IPC clusters under flow condition, respectively. Live cells were stained
with calcein (Green), dead cells were stained with Ethidium bromide (Red). Scale bar:
100 µm.
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3.3.5 Survival of 3D Co-Culture Tissues Under Static and Flow Culture Conditions

Figure 3.11 Schematic of a Co-culture Gel. A fully assembled co-culture gel had
dissociated IPCs (green) embedded in a 0.5 mm thick collagen gel. This IPC gel was
sandwiched between two layers of mESC-ECs, which were further sandwiched using
a top and a bottom collagen gel layer. Flow was applied directly through the gel using
a peristaltic pump using microbore tubing.

A schematic of the co-culture gel setup is shown in Figure 3.11. Live dead staining
demonstrated high IPC viability in both static and flow conditions as shown in Figure
3.12.

77

Figure 3.12 Live Dead Staining of 3D Co-culture Tissues. Live dead staining after 5
days of culture showing high viability of IPCs in both static and flow gels. Scale bar:
100µm.

3.3.6 Insulin Expression by IPC clusters in 3D Monoculture Gels

Figure 3.13 Insulin Expression by IPCs in 3D Gels. Immunofluorescence studies
showing IPC clusters stained positive for Insulin (red) expression in tissues cultured
(A) statically and (B) under flow for 3 days. Nuclei were stained blue using DAPI.
Scale bar: 50 µm.
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Figure 3.14 Insulin ELISA Assay. An insulin ELISA was performed followed by a
glucose challenge on IPCs in 3D collagen gels. (n=4). 2D: IPCs isolated and plated on
2D surface, SW: Static tissue containing whole IPC clusters, FW: Tissue containing
whole IPC clusters under flow, SD: Static tissue containing dissociated IPC clusters,
FD: Tissue containing dissociated IPC clusters under flow (n=4).

After three days of culture, both the static and flow gels were found to produce insulin as
shown in Figure 3.13. The presence of insulin protein was detected using
immunofluorescence labeling. This provides evidence that the IPC clusters were able to
maintain their capacity to produce insulin in the 3D culture conditions. Further tests were
done to check if the IPC clusters were able to upregulate their insulin secretion levels
based on the glucose conditions they were exposed in 3D collagen tissues. A glucose
challenge was performed on tissues containing whole IPC clusters as well as dissociated
IPC clusters. Our results showed that there was no significant effect of culture conditions
on the final insulin secreted level, nor the glucose responsiveness of IPCs. Only the
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insulin secretion of static tissue containing whole IPC clusters was significantly different
from that of 2D culture when exposed to higher glucose concentration (n=4, p<0.05).
3.3.7 Glucose Responsiveness of IPCs in 3D Co-culture Tissues

Figure 3.15 Glucose Responsiveness of 3D Co-culture Tissues. An Insulin ELISA
assay revealed the insulin secretion from the 3D coculture tissues under static and
flow conditions at low and high glucose conditions. Isolated IPCs plated on 2D
culture conditions were used as control. (n=4)

A glucose challenge followed by an insulin ELISA demonstrate that there was a
significant decrease in insulin secretion in high glucose condition compared to lower
glucose condition within the 2D culture group. However, no significant difference was
observed in the 3D co-culture conditions in either static or flow conditions as shown in
Figure 3.15 indicating that IPCs in 3D co-culture conditions are not glucose responsive.
3.3.8 Gene Expression Analysis of IPC Clusters in Monoculture Gels
In order to characterize gene expression of IPC clusters in 3D culture conditions, RNA
was isolated from 3D collagen tissues cultured for 5 days. Freshly isolated IPCs
identified by DTZ staining were used as 2D control. Table 3.1 lists all the primer
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sequences used and their respective product length. Relative gene quantification was
performed using the Livak method. As shown in Figure 3.16, IPCs in 2D as well as 3D
culture conditions were found to express genes such as Ins 2, PDX1, Pax4, Nkx6.1, Glut2
and EphrinA5.
Glut 2 expression was found to reduce 0.69 fold and 0.17 fold, respectively for
IPC cluster gels cultured under static and flow culture conditions, compared to the 2D
culture. In case of the dissociated IPC cluster gels, the Glut 2 expressions reduced 0.184
fold and 0.311 fold for static and flow culture conditions, respectively. A large variability
was seen in the insulin gene expression between the different IPC cluster gel samples.
The values obtained were not found to be statistically significant.
Nkx6.1 expression in statically cultured whole IPC gels reduced 0.29 fold and
0.47 fold for the ones cultured under flow conditions. The dissociated IPC cluster gels
under static conditions had a 1.74 fold increase over the control sample, while the
corresponding gel in flow conditions had a 0.33 fold reduced expression of Nkx6.1.
Compared to 2D culture, PDX1 expression was found to reduce 0.45 fold and
0.89 fold, respectively for IPC cluster gels cultured under static and flow culture
conditions. In case of the dissociated IPC cluster gels, the PDX1 expression reduced 0.41
fold and 0.36 fold for static and flow culture conditions, respectively.
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Figure 3.16 Gene Expression Analysis of IPCs Cluster Gels. Whole and dissociated
IPC cluster gels cultured under static and flow conditions were used for real time PCR
analysis. Relative gene quantification was performed using the Livak method [9].
GAPDH was used as housekeeping control. Freshly isolated IPCs identified by DTZ
staining were used as control (n=4). DTZ+:DTZ positive IPC clusters, SW: Whole
IPCs in static condition, FW:IPC clusters in flow condition, SD: Dissociated IPCs in
Static condition, FD: Dissociated IPCs in flow condition.
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It was also found that the Pax4 expression reduced 0.2 fold and 0.37 fold,
respectively for IPC cluster gels cultured under static and flow culture conditions
compared to 2D culture. The Pax4 expression in case of the dissociated IPC cluster gels
reduced 0.69 fold and 0.51 fold for static and flow culture conditions, respectively.
EphrinA5 expression was found to reduce 0.37 fold and 0.38 fold, respectively in IPC
cluster gels cultured under static and flow culture conditions compared to the 2D culture.
In case of the dissociated IPC cluster gels, the PDX1 expression reduced 0.66 fold and
0.83 fold for static and flow culture conditions, respectively.
3.3.9 Gene Expression Analysis of IPC Clusters in Co-Culture Gels
Gene expression analysis on 3D co-culture gels cultured for five days demonstrated that
IPCs in 2D as well as 3D co-culture conditions express genes such as Ins 2, PDX1, Pax4,
Nkx6.1, Glut2 and EphrinA5.
Insulin gene expression was significantly down regulated under flow compared to
static conditions in the 3D culture. Glut2 expression in the 3D co-culture tissues under
static and flow conditions had decreased to 0.12 fold and 0.07 fold, respectively,
compared to 2D culture. For EphrinA5, the 3D co-culture tissues under static and flow
conditions decreased 0.35 fold and 0.12 fold, respectively, while for Nkx6.1 a 0.65 fold
and 0.62 fold reduction was observed for 3D co-culture tissues under static and flow
conditions. It was found that the PDX1 gene expression in the 3D co-culture tissues
under static and flow conditions had decreased to 0.35 fold and 0.32 fold, respectively for
Pax4, 0.39 fold and 0.17 fold, respectively. Overall, a down regulation of beta cell
specific markers was observed in the 3D co-culture gels under both static and flow
culture conditions compared to 2D conditions.
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*

Figure 3.17 Gene Expression Analysis of 3D Co-culture Tissues. Real time PCR
analysis was done to study the gene expression levels of various genes of interest
such as Glut2, insulin, Pax4, PDX1, Nkx6.1 and EphrinA5. Co-culture tissues
under static and flow conditions for five days were used. Relative gene
quantification was performed using the Livak method [9]. GAPDH was used as
housekeeping control. Freshly isolated IPCs identified by DTZ staining were used
as control (n=4, p<0.05).
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3.4 Discussion
The present study describes preliminary optimization and characterization of
differentiated IPC clusters in 3D culture conditions, and their subsequent co-culture in 3D
with ECs. While previous studies have shown the beneficial effect of collagen on islet
culture [116, 225], studies using 3D collagen with stem cell derived IPCs have not yet
been demonstrated. Thus, attempts were done to optimize a few experimental conditions
to develop 3D collagen tissues with IPCs.

To derive IPC clusters with size

physiologically relevant to the islets, cannulas were used to manually break the IPC
clusters. While obtaining smaller size IPC clusters, large number of dead cells and debris
were also seen in culture. In order to prevent these from carrying forward in culture,
various strategies were tried for their removal. It was observed that filtering the IPC
cluster suspension through a cell strainer effectively removed most dead cells and debris,
when compared to pre-plating method.
Once smaller IPCs were achieved, they were cultured in 3D environment. Our
study showed that the majority of the IPC clusters remained viable after embedding in 3D
collagen gels. However, an increase in glucose responsiveness was not observed in the
3D culture conditions used in the current study. The final concentration of the gel used in
this study was 3 mg/ml., which is shown to have a pore size of ~1.8 µm [241]. However,
concentration of the collagen should be further optimized as stiffness of the gel can affect
the behavior of IPCs in 3D culture.
To determine whether perfusion flow improves viability of IPCs in 3D collagen
tissue, flow was applied to the 3D tissues. Flow rate of 0.5 ml/min was chosen as it has
previously been demonstrated that this value corresponds to a shear stress of
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approximately 0.71 dyn/cm2, which has been shown to be in the physiological range in
microvessels in in vivo conditions [238]. This flow-rate was chosen to minimize gel
compaction of the 3D tissues due to high velocity of flow. Our studies with endothelial
cells (Chapter 4) demonstrated that the cell seeded collagen gels underwent significant
compactions when exposed to 2 ml/min flowrate. This compaction was reduced upon
changing the flowrate to 0.5 ml/min.
Upon live dead staining, it was found that the IPC cluster viability was higher in
static culture conditions compared to the flow culture conditions. Dead cells were found
on the outer edges of the IPC clusters. This was not expected as islets in perifusion
studies that are exposed to higher flow rates ranging from 130 µl/min to 1 ml/min survive
without a problem [141, 242]. Further studies are required to examine the effect of lower
flow rate as well as shorter culture period on IPC function in 3D culture. The difference
is the duration of exposure. Perifusion can last from a few min to a few hours whereas
our study continued for 5 days. 3D collagen gels were cultured for 5 days to detect any
changes in gene expression, which may not be reflected in short term studies. Since
individual rat islets in vivo are normally exposed to a flowrate of 2 x 10-5 ml/min of blood
[142, 243], it is possible that much lower flow rate needs to be tested. It is not clear from
the study whether similar cell death will occur at lower flow rates or shorter culture
period. Thus, more experiments are required to better understand the effects of flow on
IPC clusters.
It was observed that the IPC clusters lose their glucose responsiveness once they
are isolated out of the differentiation plate. Isolated IPCs plated on 2D surface as well as
the ones incorporated in 3D collagen gels cultured under static and flow culture
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conditions displayed this lack of glucose responsiveness. Prior to isolation of IPCs, IPCs
were glucose responsive. Past studies have reported evidence that exposure to high
glucose medium de-sensitized rat and human islets and impaired their function in
response to a glucose challenge [221, 244, 245]. The medium used in this study contained
about 17.5 mM of glucose and as this is considerably high, it is possible that the cells
were rendered glucose unresponsive because of exposure to the medium. Assady et al. in
their ground breaking study that described the first derivation of IPCs by hES cells,
suggested that the high glucose conditions of the differentiation medium might make the
IPCs unresponsive to glucose [76]. It was suggested by this group that switching
differentiating cells to a low glucose medium during the last stage of differentiation
might be able to restore the glucose responsiveness [76]. Thus, whether this is due to
desensitization of IPCs in high glucose containing culture medium awaits further studies.
Prior to the gel preparation, IPC clusters were manually handpicked from their
environment in the differentiation culture, which caused separation of IPCs from the
basement membrane proteins as well as from the neighboring cells. Since, laminin and
collagen type IV are produced by cells in our culture and they are known to be important
in insulin gene regulation and support glucose stimulated insulin release [246], it is
plausibe that the loss of these basement membrane proteins may have led to the loss of
glucose responsiveness for the IPC clusters when they were transferred in collagen gels
or plated in 2D culture conditions. In fact, previous studies have indicated that a
combination of collagen and Matrigel can help maintain insulin gene expression of islets
in culture [221, 225]. Future studies exploring a combination of collagen with other
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ECM proteins such as laminin or Matrigel are needed to determine their effects on IPC
function in 3D in vitro conditions.
It is also possible that the IPCs may have undergone transdifferentiation in culture
[247]. Although studies have shown that collagen provides a permissive environment for
islet organization and helps maintain islets in culture for a longer time [221], there have
also been a few reports that have shown that islets embedded inside collagen gels
transdifferentiated into duct like cells [248, 249]. Further studies are needed to verify
whether transdifferentiation has occurred by examining the expression of ductal cell
markers such as cytokeratin 7,19 and 20 [250].
Past studies have highlighted the beneficial effect of endothelial cells on islet
culture. Endothelial cell secreted factors improve insulin gene expression, beta cell
proliferation and growth [1, 145, 150, 151, 154, 165, 205, 251, 252]. In the present study,
we used ECs and IPCs derived from mES cells to develop 3D co-culture gel tissues.
These co-culture tissues were cultured up to 5 days in static and flow culture conditions.
Live dead staining at Day 5 showed that most of the cells in the co-culture maintained
their viability after five days of culture. Although the insulin gene expression levels were
comparable to that of 2D clusters, the 3D co-culture gels showed diminished glucose
responsiveness. The basal level of insulin expression was about 8 µg/ml when the cells
were exposed to low glucose levels. This is about four times higher than the response of
DTZ+ clusters in 2D conditions as shown in Chapter 2, section 3.4. In 2D conditions, the
cells had secreted less than 2 µg/ml of insulin when exposed to 2.5 mM of glucose and ~8
µg/ml upon exposure to 27.7 mM of glucose. But in 3D condition, the cells secreted 8
µg/ml of insulin when exposed to 2.5 mM of glucose and upon exposure to 27.7 mM
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glucose no significant increase in insulin secretion was observed. This presents evidence
that the IPC clusters were not responding to glucose levels.
The high level of insulin expression at the low glucose stimuli can be explained
by the fact that the 3D co-culture gels had more IPCs packed together compared to the
2D culture and which may have resulted in higher insulin release compared to that in 2D
culture condition. This however, does not explain why the cells did not upregulate their
insulin levels upon high glucose exposure.
A study by Boyd et al. showed that the number of islets plays an important role in
determining the end result of a glucose challenge test. In their study, 600, 300, 100, 66,
55and 25 islets were cultured separately. Upon performing a glucose challenge at 3.3mM
and 25 mM glucose, only the first two groups i.e., 600 and 300 islets behaved in a
glucose responsive manner [88]. When this procedure was repeated using IPC clusters
derived from mES cells, similar results were obtained [88]. Therefore further studies are
needed to examine whether increasing the number of IPC clusters will have a positive
effect on the IPC culture in our study.
In addition, a previous study by Song et al., showed that when cultured with rat
endothelial cells, islets were not glucose responsive up to 5 days. However, a difference
was noticed between day 7-14 of the co-culture [253], when the islets became glucose
responsive. This suggests that the effect of endothelial cell co-culture on islet glucose
responsiveness might not be immediate and requires longer time to fully manifest. As our
study only lasted for 5 days, it will be interesting to see the impact of a longer duration on
the glucose responsiveness of the co-culture tissues.
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Gene expression analysis showed that EphrinA5 expression was not increased in
flow co-culture conditions as hypothesized. On the contrary, the EphrinA5 expression
was found to be higher in static co-culture gels compared to flow co-culture gels. The
reason for this was not understood and hence the interaction between the EphB2 and
EphrinA5 was not analyzed as initially described in the specific aim III.
Jaramillo et al. used a co-culture of ECs while differentiating human embryonic
stem cells into IPCs [254]. In this study, the authors showed that the direct co-culture of
endothelial cells resulted in higher insulin expression when compared to transwell
cultures and exposure to conditioned medium from endothelial cells [254]. It is
noteworthy that the IPCs were differentiating while they were exposed to ECs, which is a
different condition compared to the presented study where the differentiated IPCs were
co-cultured with ECs. Whether the ECs have a more beneficial effect during or after the
differentiation process is not clear.
Previous studies have also highlighted the role ECs play in the development of
diabetes type I. ECs can get activated by cytokines and then make large quantities of NO,
that can cause beta cell death [255]. An interesting study by Steiner et al., showed that in
co-culture of islet endothelial cells and islet cells, the endothelial cells acted as effector
cells and were able to mediate strong to complete lysis of islet cells [256]. Such lysis is
preceded by DNA strand breaks with no morphological evidence of apoptosis [256-258].
Although extensive cell death was not observed in the co-culture system in the presented
study, there was however a downregulation of key beta cell markers in the co-culture
environment in both static and flow culture conditions. Measuring the NO levels in the
co-culture experiments and checking the DNA strands for signs of breakage can give an
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insight into the cell-to-cell interactions between the IPCs and mESC-ECs. NO levels can
be measured by performing an NOS ELISA assay, but was not performed in the interest
of time. Checking DNA strands for breakage was beyond the scope of this work and
hence was not performed.
The presented chapter describes strategies for 3D encapsulation of IPC clusters
and their detailed characterization. It also describes useful strategies to prepare 3D coculture gels using IPCs and mESC-ECs. Although the survival rate was high in the
monoculture and co-culture gels, an improvement in the glucose responsiveness was not
observed. Further, a downregulation of key beta cell markers was seen in the 3D culture
conditions. Further studies with different culture conditions will need to be performed to
collect more evidence on the effects of 3D environment and flow on the survival and
functionality of IPC clusters in in vitro conditions. Longer duration of culture and a
switch to low glucose conditions during the final stages of differentiation might improve
the outcomes of the co-culture. Rigorous optimizations will be required to improve the
glucose responsiveness and genetic profile of the co-culture tissues before they can be
used for any therapeutic applications.
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CHAPTER 4
DIFFERENTIATION OF MOUSE EMBRYONIC STEM CELLS INTO ISLET
ENDOTHELIAL CELLS

4.1 Introduction
Several efforts have recently been made to differentiate pluripotent stem cells into
endothelial progenitor cells or endothelial cells using various strategies (2,10,17,38,66).
These pluripotent stem cell derived endothelial cells can provide an abundant cell source
for tissue engineering applications as well as more personalized medical treatments.
Levenberg et al. reported the derivation of endothelial cells from human embryonic stem
cells (hESCs) and Blancas et al. demonstrated a chemically defined protocol to
differentiate mouse embryonic stem cells (mESC) into endothelial cells (9,10). Other
groups have shown that fluid shear stress can promote an endothelial-like phenotype from
early embryonic stem cell differentiation (31,65) and the role of matrix stiffness has also
been explored for endothelial differentiation (16,71). Recently, Nolan et al. established a
library of molecular signatures of tissue-specific microvascular endothelial cells. They
demonstrated that when murine embryonic stem cell-derived endothelial cells were
transplanted into animal models, the generic endothelial cells acquired the specific
characteristics of the tissues in which they were transplanted (46). Notably, endothelial
cells are recognized as a heterogeneous cell population in their structure and function
based on the location in the body (3). However, protocols for in vitro stem cell
differentiation into organ-specific endothelial lineages are not yet available
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Endothelial cells found in pancreatic islets, known as islet endothelial cells (IEC)
are being increasingly appreciated as an important contributing factor in pancreatic islet
development and maturation (28,67), as pancreatic islets have a very dense capillary
network in vivo. IECs are known to exhibit a unique phenotype and markers that
distinguish them from neighboring endothelial cell populations. It has previously been
reported that isolated human IECs have more fenestrations than endothelial cells found
within the exocrine part of the pancreas (20,47,68,69). In addition to classical endothelial
cell makers such as von Willbrand factor, platelet endothelial cell adhesion molecule
(PECAM1), and uptake of acetylated- low density lipoprotein (LDL), IECs are shown to
express unique markers including nephrin and alpha1-antitrypsin (AAT) (43,69). Other
studies have shown that rat IECs constitutively express endothelial nitric oxide synthase
(eNOS) and the expression of eNOS is glucose-dependent unlike other endothelial cells
(56,68,69). These unique properties of IECs contribute to normal development of beta
cells in the pancreas. IECs secrete various molecules such as collagen type IV (29),
laminin (26,45,61), connective tissue growth factor (CTGF) (14) and hepatocyte growth
factor (HGF) (27) that are important for insulin secretion, beta cell proliferation,
differentiation and endocrine lineage specification. Recent studies have also highlighted
the role of IECs in the revascularization and stabilization of transplanted islets in the host
tissue (11). Mattsson et al. showed that the expression of angiogenic and inhibitory
factors by IECs varied at different time points post transplantation (44). However, due to
difficulty in isolating a pure population of IECs and expanding in in vitro culture, the
information on IECs is still relatively limited.
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In the current study, we report the first demonstration of endothelial cells
exhibiting IEC markers differentiated from mESC. This population of IECs appeared as a
side-product in the differentiation culture of mESC into pancreatic beta cells. A pure
population of endothelial cells was successfully isolated from the vicinity of insulinproducing cells and expanded in in vitro culture for further characterization. These highly
purified endothelial cells with islet specific characteristics will further enhance our
understanding of tissue-specific endothelial cell function. Moreover, studies investigating
the interaction between neighboring insulin-producing beta cells and IECs can lead to a
significant step in formulating new therapeutic angiogenic approaches for diabetes.
4.2 Materials and Methods
4.2.1 Identification and Isolation of mESC-Derived Endothelial Cells (mESC-ECs)
MESC were used to derive insulin producing cells (IPCs) of the pancreatic beta lineage
as described in Chapter 2 Section 2.2. During various stages of mESC differentiation into
pancreatic beta cells, acetylated Dio-LDL (Biomedical Technologies Inc., Stoughton,
MA) was used to identify a mature endothelial cell population in the culture. LDL
working solution was prepared by diluting LDL 1:10 in culture medium in the dark.
Medium was removed from cells, LDL was added and the dishes were wrapped in
aluminum foil and incubated for 4 hours at 37 °C. LDL positive cells were detected as
stained green under an inverted florescence microscope (IX81 DSU, Olympus).
At the end of the differentiation process, i.e.,, Day 33, LDL positive cells in
culture were selectively isolated from the rest of the population using sterile cloning discs
(Capitol Scientific, Austin, TX). Dishes were washed 2X with warm PBS to remove
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traces of medium. The sterile cloning discs were treated for ten minutes with UV light to
further sterilize them. Using a fine tip forceps, 1-2 cloning discs were added to an aliquot
of 0.25% trypsin and pre-treated for 5-10 minutes. They were then added carefully on
previously marked areas with a large subpopulation of LDL positive cells and incubated
for 3 min at 37°C. At the end of the incubation, the discs were gently lifted from the top
and placed in a new dish coated with 0.1% gelatin and were initially cultured in the
pancreatic differentiation medium supplemented with 10% FBS. After a few passages,
culture medium was replaced with MCDB complete endothelial growth media containing
10% FBS, 1% penicillin-streptomycin (Sigma Aldrich), and Endogro, an endothelial cell
growth supplement from VEC Technologies. Cells were passaged at 70-80% confluence
and the cell culture medium was exchanged every 2-3 days.
4.2.2 FACS Analysis of mESC-ECs
Fluorescence-activated flow cytometry (FACS) was used to confirm the phenotype and
the purity of the isolated cell population. For FACS analysis, cells were fixed with 4%
PFA for 30 min and then washed 3X with PBS. Cells were then permeabilized with
0.25% Triton-X for 5 min. at room temperature. Cells were centrifuged to remove TritonX and re suspended in ice cold FACS buffer. After incubation at 4 °C for ten minutes,
cells were incubated with a polyclonal rabbit anti-PECAM1 (1:20, Santa Cruz) in FACS
buffer (PBS with 1% BSA and 2 mM EDTA) for 30 minutes at 4 °C. Cells were then
washed three times with cold PBS and secondary donkey anti-rabbit APC (1:20, Fisher
Scientific) was added and incubated for 30 minutes at 4 °C. Cells were again washed
three times with cold PBS. Cells were analyzed using a FC500 Flow cytometer (Beckman
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Coulter, Pasadena, CA) and FlowJo software at the FACS facility at Rutgers Medical
School.
4.2.3 Western Blot Characterization of mESC-ECs
A detailed characterization of cell phenotype was performed using western blotting
analysis. For making cell lysates, cells were washed twice with ice cold PBS, and then
incubated with cell lysis buffer (See Appendix B for details) for 20 min at 4 °C. The cells
were then gently scraped off using a cell scraper (USA scientific) and then added to a
microcentrifuge tube. Tissue lysates were made by first grinding the tissue over dry ice,
making sure that it remains frozen throughout the process. The powdered tissue was then
transferred to a microcentrifuge tube with the lysis buffer and incubated at 4 °C for 20
min. The lysates were centrifuged at 4 °C for 30 min at 14,000 rpm in a microcentrifuge.
The supernatant was transferred into a fresh tube and used for protein quantification
using the Bradford or DC assay (See Appendix X for details). The results were read using
the Smart Spec Spectrophotometer (BioRad). Cell lysates were diluted (1:1) in Laemmli
buffer (Bio-Rad, Hercules, CA) containing 5% mercaptoethanol and 2% sodium dodecyl
sulfate (SDS). The lysates were stored in 25-30 µg aliquots and stored at -20 °C till ready
for use.
2D gel electrophoresis was performed using Miniprotean TGX precast gels
(BioRad). Dual color precision plus protein standard (BioRad) was used as a protein
marker. The gels were transferred on Immunoblot PVDF membranes (BioRad) at 100 V
for 90 minutes at 4 °C. For immunoblotting, primary antibodies used were a polyclonal
rabbit anti-PECAM1 (1:200, Santa Cruz), a monoclonal mouse anti-thrombomodulin
(1:200, Abcam), a monoclonal mouse anti-ICAM1 (1:500 Abcam), a polyclonal rabbit
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anti-eNOS (1:200, Abcam), a polyclonal rabbit anti-EphB2 (1:200, Santa Cruz), a
polyclonal goat anti-EphB4 (1:200, Santa Cruz), a polyclonal rabbit anti-Notch-1 (1:100,
Santa Cruz), a polyclonal rabbit anti-Nephrin (1:250, Abcam) and a monoclonal mouse
anti-β actin (1:2000, Sigma). After three washes with TBS-Tween buffer, blots were
incubated with a secondary goat anti-rabbit IgG HRP, a goat anti-mouse IgG HRP
antibodies or a goat anti-donkey IgG HRP antibody (1:2000, Santa Cruz) for 1 hour at
room temperature. After three washes with TBS-Tween buffer and one wash with TBS
buffer, the blots were developed using a Supersignal chemiluminescent substrate
(Thermoscientific, Rockford, IL). Blots were incubated with 3 mls of 1:1 ratio of the
Supersignal substrate solution and Supersignal enhancer solution in the dark. Blots were
then exposed to UV and developed using a Chemidoc XRS (BioRad). Fresh rat aortic
tissue homogenates and low passage of cultured rat aortic endothelial cells (RAEC)
lysates were used as controls. mESC-EC lysates from passages 6-16 were used.
4.2.4 Deposition of ECM Proteins by mESC-ECs
To determine whether mESC-ECs deposit basement membrane proteins in culture, cells
were cultured on glass slides for 5-7 days for immunohistological evaluation. Cells were
fixed for 30 minutes at room temperature using 4% PFA (Boston Bioproducts) and then
washed three times with PBS. Cells were then blocked with 10% horse serum in PBS
with 0.1% Tween-20 for 30 minutes followed by an overnight incubation with primary
antibodies at 4 °C. Primary antibodies used were a polyclonal goat anti-laminin (1:200,
Santa Cruz), a polyclonal rabbit anti-collagen type IV (1:200, Santa Cruz) and a
polyclonal rabbit anti-fibronectin (1:200, Santa Cruz). Cells were washed 3X with PBS
and then incubated with secondary donkey anti-goat (1:200, Santa Cruz) and goat anti-
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rabbit (1:200, Santa Cruz) for 30 minutes. Cells were counterstained with hematoxylin
(Boston Bioproducts, Ashland, MA), and mounted using Permount (Fisher Scientific,
Hampton, NH). Cells were imaged using an inverted microscope with a color camera
(Nikon Eclipse Ti-S, Japan).
4.2.5 Immunofluorescence Characterization
To determine the expression of FLK1 by mESC-ECs, immunofluorescence analysis was
performed. Cells were fixed for 30 minutes at room temperature using 4% PFA (Boston
Bioproducts) and then washed 3X with PBS. Cells were then blocked with 10% goat
serum in PBS with 0.1% Tween-20 for 1 hr. followed by an overnight incubation with a
polyclonal rabbit anti-Flk-1 (1:1000, Abcam) at 4°C. Cells were washed 3X with PBS
and then incubated with secondary goat anti-mouse (1:2000, Abcam) for 1 hour. Cells
were stained with DAPI to visualize the nuclei and were imaged using a confocal
microscope (IX81 DSU, Olympus, Somerset, NJ).
4.2.6 Endothelial Nitric Oxide Synthase (eNOS) Expression by mESC-ECs
ENOS Enzyme linked immunosorbent assay (ELISA) kit (R&D systems, Minneapolis,
MN) was used to quantify eNOS expression by cultured mESC-ECs. Cells cultured in
MCDB complete endothelial growth media containing 17.5 mM of glucose were first
examined. Cells were then exposed to culture medium containing higher glucose
concentrations of either 25 mM or 35 mM of glucose for 24 hours to investigate whether
eNOS expression by mESC-ECs was dependent on glucose concentrations. The cells
were lysed and the lysates were collected to be analyzed by ELISA. The ELISA results
were read using an Emax microplate reader (Molecular Devices, Sunnyvale, CA) at the
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wavelength of 570 nm. A student T-Test was performed to check whether the data was
statistically significant.
4.2.7 Vascular Endothelial Growth Factor (VEGF) Expression by Cells During
Pancreatic Differentiation Process
VEGF concentration in the culture medium during the pancreatic differentiation process
was quantified using a VEGF ELISA kit, following manufacture’s instruction (R&D
systems, Minneapolis, MN). Culture medium was collected at various time points,
including day 20, 26 and 32 of pancreatic differentiation. In addition, culture medium
was collected from mESC-ECs culture, to determine VEGF expression by endothelial
cells. Fresh differentiation medium was used as a control. The ELISA results were read
using an Emax microplate reader (Molecular Devices, Sunnyvale, CA) at the wavelength
of 570 nm. A student T-Test was performed to check whether the data was statistically
significant.
4.2.8 Matrigel Assay
A 0.8 mm thick layer of Matrigel (BD Biosciences, San Jose, CA) was prepared by
adding Matrigel diluted in ice-cold DMEM (1:1) into a well of a 12 well plate. 1.5x104
mESC-ECs were seeded onto the layer of Matrigel and cultured for up to 48 hours. Cord
formation by mESC-ECs was imaged using a microscope with a color camera (Nikon
Eclipse Ti-S, Japan).
4.2.9 Preparation of a Sandwiched Collagen Gels Using mESC-ECs
3D Collagen gels were constructed using a modification of the sandwich method
previously described [259] as shown in Figure 4.12. The original method describes the
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preparation of a collagen gel with one layer of cells sandwiched between two gel layers.
The method was modified to include up to three layers of cells embedded in between the
collagen gel layers. Further modification was done to reduce the gel preparation time
from 72 hours to 9 hours. Rat tail collagen type I (BD Biosciences), 10X DMEM (Sigma
Aldrich) and 10X reconstitution buffer (0.05 N NaOH with 0.16 M HEPES and 0.25 M
NaHCO3) were mixed to form a collagen solution with final concentration of 3 mg/ml.
To form 3D collagen gels, collagen solution was first poured into tissue culture plates and
incubated at 37°C for 30 minutes to allow polymerization before mESC-ECs suspended
in MCDB complete medium were added on top. After 3 hours, medium was carefully
removed and another layer of cold collagen gel solution was added on top of the cell
layer. This process was repeated to obtain in total two layers of cells sandwiched between
three layers of collagen gel. Medium was changed every other day. After 3-5 days in
culture, collagen gels were fixed overnight in 4% PFA at room temperature.
4.2.10 Lumen Formation in mESC-EC Seeded Collagen Gels
Fixed collagen gel samples were paraffin-embedded and histological sections were
prepared for immunofluorescent analysis (Core histology Lab, Rutgers Medical School).
The samples were de-paraffinized by a series of washes (See Appendix X for details).
The sections were incubated with an antigen retrieval buffer (10 mM citric acid, pH = 6)
at 95 °C for 25 minutes and then allowed to cool down for 20 min. They were incubated
with 10% goat serum and 0.1% Triton-X in PBS for 1 hour for blocking followed by
incubation with a polyclonal rabbit anti-PECAM1 (1:200, Santa Cruz) at 4 °C overnight.
After 3x wash with PBS, collagen gel sections were incubated with a secondary donkey
anti-rabbit (1:200, Santa Cruz) for 1 hour at room temperature over a rocker. DAPI
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(Vector labs) was used to stain the nuclei. Images were acquired using a confocal
microscope (IX81 DSU, Olympus, Somerset, NJ) and were merged using Image J
software (NIH).
4.2.11 Effect of VEGF Inhibitor on mESC-ECs Yield
To determine whether the presence of VEGF is one of the critical factors contributing to
the appearance of mESC-ECs in pancreatic differentiation culture, Thalidomide (Sigma),
which is known as a potent inhibitor of angiogenesis [260] was added to the
differentiation culture on day 15 at a final concentration of either 10 µM or 20 µM in the
culture medium. At the end of the differentiation (Day 33), cells were incubated with
LDL as previously described and monitored under a florescence microscope.
4.2.12 Application of Flow to mESC-EC Seeded Collagen Gel
A custom made bioreactor set up was used for this study [238]. The collagen mESC-EC
mix was pipetted onto a polyethylene terephthalate (PET) membrane glued on a PDMS
ring placed on the inside edge of the bottom piece of the flow bioreactor. This porous
membrane supported the gel during the experiment. To prevent the gel from moving and
undergoing contraction by cellular action, six 27G needle pins were inserted around the
periphery of the PDMS ring. To reduce the resistance to flow created by the membrane,
15-20 holes were punched into it using a 30 gauge needle. During the gel preparation
when subsequent layers were being added to the gel, it was placed inside a small sterile
plastic container (Nalgene) in the incubator. Once all the gel layers were added, the
bioreactor was fully assembled inside the laminar flow hood. First a PDMS ring was
placed on top of the gel and pushed down upon the needle pins. This was done carefully
without disturbing the gel beneath. This ring formed a flow orifice in the system and
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forced the medium to flow through the gel. It prevented the medium from taking the path
of least resistance and flowing around the gel. Medium was added to the gel so that the
bottom piece was completely full of medium. The bioreactor was assembled as described
in Chapter 3. Once the bioreactor was fully assembled, it was connected to a peristaltic
pump (Cole Parmer) via cartridges. Flow-rate and flow direction were set and the flow
was started at 0.5 ml/min. Flow was continued for 1-10 days.
4.2.13 Actin Staining
Fixed collagen gels were stained with Rhodamine Actin Phalloidin (Life technologies)
diluted 1:20 with PBS in the dark for 2 hrs on a rocker. Afterwards, the gels were washed
3x with PBS on a rocker. Samples were stained with DAPI to visualize the nuclei and
mounted with a coverslip for imaging. A DSU unit attached to an inverted fluorescence
microscope (Olympus) was used to take z-sections of the gels. Cell sens software was
used to combine the z-sections to acquire a 3D image of the gel samples. Deconvolution
was performed using the Image J software (NIH).
4.2.14 ECM Protein Staining in Differentiation Culture
This was done to demonstrate whether the mESC-ECs were capable of depositing
basement membrane proteins in the differentiation culture, prior to their isolation. DTZ
positive clusters were marked in a differentiation plate and the plates were fixed for 4
hours with 4% PFA. After 3X washing with PBS, the cells were blocked with 10% goat
serum and 0.1% Triton-X 100 in PBS for 1 hour at room temperature. Primary antibodies
polyclonal goat anti-laminin (1:200, Santa Cruz), a polyclonal rabbit anti-collagen type
IV (1:200, Santa Cruz) were added for overnight incubation at 4 °C. Cells were washed
3X with PBS and then incubated with secondary donkey anti-goat (1:200, Santa Cruz)
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and goat anti-rabbit (1:200, Santa Cruz) for 30 minutes. Cells were counterstained with
hematoxylin (Boston Bioproducts, Ashland, MA) to visualize the nuclei.
4.2.15 Addition of VEGF to Promote Angiogenesis
Lyopholized recombinant VEGF powder (R&D systems) was resuspended in sterile PBS
containing 0.1% BSA (Bovine serum albumin) to make a 100 µg/ml stock solution. This
solution was then aliquoted and stored at -20 °C. In order to obtain a more interconnected
and dense vasculature, recombinant VEGF was added to the medium at 5 ng/ml. VEGF
was directly added to the medium and mixed up and down by pipetting.
4.2.16 Statistical Analysis
Results are presented as mean± standard deviation. A one-way paired student T-test was
performed. Statistical significance was accepted for p<0.05.
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4.3 Results
4.3.1 Identification of mESC-ECs

Figure 4.1 Identification of Mouse Embryonic Stem Cell-Derived Endothelial Cells
(mESC-ECs). (A) A brightfield image of insulin-producing cell cluster stained with
Dithizone (DTZ) is shown in red. (B) Cells surrounding DTZ positive cell cluster are
stained green by the uptake of acetylated Dio-LDL. Scale bar, 100 µm. (C) A time line
with important milestone marks during differentiation of mESC into pancreatic beta
cells. Embryoid bodies (EBs) formed by a hanging drop method were plated at day 6.
A definitive endoderm marker, FoxA2, was first detected at day 15. LDL positive cells
started to appear at day 20. The mESC-ECs were isolated on day 33, which
corresponds to the end of pancreatic differentiation. Scale bar: 100µm.

IPCs were obtained successfully from mESC using a previously established protocol [73],
as described in detail in Chapter 2. Insulin-producing cell clusters were identified after 33
days of differentiation by staining with DTZ as shown in Figure 4.1A. Interestingly, in
the vicinity of DTZ positive cell clusters, we have detected a population of cells that
uptake LDL (Figure 4.1B). By examining the differentiation culture at various time
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points, we found that the LDL positive cells start to appear as early as day 20 of
differentiation (Figure 4.1C). It was also found that the number of LDL positive cells
progressively increases, reaching approximately 6.3±0.9% of the total number of cells on
the final day of differentiation, day 33 as shown in the Figure 4.2.

Figure 4.2 Yield of mESC-ECs. The average yield of mESC-ECs was ~6.3% (n=3). This
was calculated by counting the LDL positive cells and the total number of cells in a well.

4.3.2 Characterization of mESC-ECs
Isolated mESC-ECs positive for LDL were expanded and cultured for up to 15 passages.
Cultured mESC-ECs exhibited a cobblestone morphology as shown in Figure 4.3A. To
determine whether these cells express an endothelial cell adhesion marker, PECAM1, a
western blot analysis was performed on cells at various stages of differentiation. It was
found that while undifferentiated mESCs and cells differentiated for up to 15 days do not
express PECAM1, only isolated and cultured mESC-ECs express PECAM1 (Figure
4.3B). In order to determine the purity of the cultured cell population, a FACS analysis
using PECAM1 was performed. Figure 4.3C shows that 99% of mESC-ECs express
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PECAM1, confirming that the isolated cell population is a pure endothelial cell
population.

Figure 4.3 Characterization of mESC-ECs. (A) A representative phase contrast image
showing mESC-ECs (Passage 7) exhibiting cobblestone morphology in culture. Scale
bar: 100 µm. (B) Western blot analysis showing PECAM1 expression only by isolated
mESC-ECs, and not by undifferentiated mESC or mESC at earlier time points of
differentiation i.e before day 15. Rat aortic tissue lysate and primary RAECs served as
positive controls and beta actin served as a loading control. (C) FACS histogram
demonstrating a complete shift of peak for PECAM1 positive mESC-ECs (green)
compared to isotype control (purple).

Moreover, immunohistochemistry results revealed that these cells express
basement membrane proteins such as collagen type IV, laminin and fibronectin in culture
(Figure 4.4 A, B and C, respectively), although difference in the protein expression level
at various culture times was not observed.
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Figure 4.4 Basement Membrane Protein Expression by mESC-ECs. Representative
immunohistochemical micrographs demonstrating the deposition of (A) collagen type
IV, (B) fibronectin and (C) laminin by cultured mESC-ECs. Scale bar : 100 µm.

Figure 4.5 Western Blot Characterization of mESC-ECs. Western blot
showing PECAM1 expression only by isolated mESC-ECs, and
undifferentiated mESC or mESC at earlier time points of differentiation i.e.,
Rat aortic tissue lysate and primary rat aortic endothelial cells served as
controls and Beta actin served as a loading control.
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Figure 4.5 demonstrates that cultured mESC-ECs express classical endothelial
markers such as thrombomodulin, eNOS and ICAM-1 in addition to PECAM1 and
EphB2.

Unlike RAECs that only express an arterial marker, Notch-1, mESC-ECs

express both venous and arterial markers, EphB4 and Notch-1, respectively. More
importantly mESC-ECs express nephrin, which is known as one of the islet endothelial
cell specific markers.

Figure 4.6. eNOS Expression in mES Cell Derived ECs. Expression of endothelial
nitric oxide synthases (eNOS) expression by mESC-ECs exposed to different
glucose levels (25mM and 35mM) in the medium. Significant increase in eNOS
expression by mESC-ECs was observed when exposed to higher glucose
concentration, demonstrating glucose-dependent eNOS expression. The DMEM/F12
culture medium containing 17.5 mM of glucose served as a control (n=3, p<0.05).

To determine whether eNOS expression by mESC-ECs is glucose-dependent,
cells were subjected to different glucose concentrations. Negligible amount of eNOS was
detected in the culture medium, which contains 17.5 mM glucose (Figure 4.6). However,
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when the cells were exposed to higher glucose concentration of either 25 mM or 35 mM,
eNOS expression was significantly upregulated (n=5, p <0.05). Since the cells were
cultured in medium containing 17.5 mM glucose, it was considered as a baseline glucose
level and 25 mM and 35 mM concentrations were chosen. However, it is important to
culture cells in low glucose containing medium to further examine the effects of glucose
concentration on eNOS expression.
As the number of mESC-ECs progressively increased in the differentiation
culture, VEGF ELISA was performed to examine the presence of VEGF in the culture,
and to determine whether VEGF plays a role in the appearance of the endothelial cell.
Culture medium was collected from various time points during the differentiation, and
fresh medium was used as a control. Culture medium used to culture mESC-EC was also
tested to identify the origin of VEGF. The VEGF ELISA results showed a significant
increase in VEGF concentrations at day 20 of differentiation compared to that of fresh
culture medium (Figure 4.7). This day 20 of differentiation coincides with when LDL
positive cells were first detected in the culture. It was also observed that the VEGF
concentration is significantly higher in culture medium at day 33 compared to day 20 of
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Figure 4.7 VEGF Expression in Differentiation Culture. VEGF concentrations in
culture medium measured at various time points (day 20, 26, and 32) during
differentiation. VEGF was significantly higher in measured time points compared to
that of fresh culture medium. Increasing trend of VEGF with more days in culture was
observed (n=3, p<0.05).

differentiation. The increase of VEGF expression in culture correlates to the increasing
number of endothelial cells as the differentiation progresses. However, since it was found
that cultured mESC-EC do not produce significant amounts of VEGF in culture, insulin
positive cells are likely to be the main source of VEGF in the differentiation culture.
Moreover, the addition of either 10 µM or 20 µM of Thalidomide, an angiogenesis
inhibitor in the culture for 18 days resulted in a significantly less number of LDL positive
endothelial cells at the end of the differentiation as shown in Figure 4.8, indicating that
VEGF is necessary for mESC-EC formation.
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Figure 4.8. Effect of Thalidomide on mESC-EC Yield. mESC-ECs exposed to
Thalidomide had reduced numbers of cells that were positive for LDL uptake (Red)
compared to the control samples (Scale bar: 100 µm).

Previous studies have suggested that beta cells are unable to form a basement
membrane on their own and hence they recruit endothelial cells to deposit basement
membrane proteins for them [154]. In order to check if the mESC-ECs were capable of
depositing basement membrane proteins in the pancreatic differentiation culture, the
dishes with DTZ positive clusters were fixed and stained with basement membrane
proteins such as laminin and collagen type IV. It was observed that the cells surrounding
the DTZ+ clusters stained positive suggesting that the endothelial cells were capable of
depositing the ECM proteins in the differentiating culture (Figure 4.9). This also
reinforces the interplay of signaling that happens between the developing beta cells and
the endothelial cells.
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Figure 4.9 Basement Membrane Protein Staining in Differentiation Culture.
Immunohistochemical staining demonstrated expression of collagen type IV and
laminin by the cells surrounding DTZ+ clusters as shown by yellow arrows. The
cells were counterstained with Hematoxylin. Scale bar: 100um.

Figure 4.10 Expression of Islet Endothelial Specific Marker by mESC-ECs at Higher
Passage. A western blot analysis demonstrated the presence of islet endothelial
specific markers such as Nephrin and AAT on mESC-ECs at Passage 8, passage 16
and in 3D collagen gels made with mESC-EC (P16) and cultured for 3 days under
static conditions. Beta actin was used as a loading control.
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In order to test whether the mES derived endothelial cells were capable of maintaining
their islet endothelial specific marker even after repeated passaging, a western blot
analysis was performed on cells from passage 16. It was found that the cells continued to
express islet endothelial specific markers such as Nephrin and AAT (Figure 4.10).
4.3.3 Angiogenic Capacity of mESC-ECs.
When mESC-ECs were cultured on a layer of Matrigel, they were able to spontaneously
organize into cord-like structures, which were maintained for up to 48 hours as shown in
Figure 4.11. This in vitro Matrigel angiogenesis assay demonstrates the angiogenic
capacity of mESC-ECs, consistent with known characteristics of endothelial cells [261].

Figure 4.11. Angiogenic Capacity of mESC-ECs. mESC-ECs plated on Matrigel
formed tube-like structures 12 hours after plating (Scale bar: 500 µm).

Furthermore, to examine mESC-EC behavior in a 3D environment, collagen gels
were created by a sandwich method, which contained two layers of cells prepared in
between three layers of collagen. The method was modified to include up to three layers
of cells embedded between the collagen gel layers. Further modifications reduced the gel
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preparation time from 72 hours to 9 hours. A schematic of the gel preparation method has
been shown in Figure 4.12 and a schematic with the final dimensions of the multilayered
sandwich gel has been shown in Figure 4.13.

Figure 4.12. Schematic of the multi layered sandwich gel making procedure. The top
figure shows the previous method that was used for making multi-decked gels. mESCECs were plated on a layer of collagen gel and allowed to spread out for 24 hours,
before another layer of collagen was added on top. This layer was allowed to incubate
for 30 minutes before adding a second layer of mESC-ECs on top. Again, the cells
were allowed to spread out for 24 hours and a third layer of collagen was added. A
total of three cell layers were added following the same procedure. After the final
layer of collagen was added the gel assembly was allowed to incubate for 30 minutes
and then medium was added. This method was optimized to decrease total gel
preparation time. The modified method had only two cell layers sandwiched between
three layers of collagen gel. Further, the cell layer was allowed to spread out for about
4 hours before another layer of collagen gel was added on top. This reduced the gel
preparation time from 72 hours to 9 hours.
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Figure 4.13. Schematic of the mESC-EC Multilayered Sandwich Collagen Gel. The
sandwich gel had two cell layers sandwiched in between the three gel layers. The gel
layers were 0.5mm, 0.2 mm/0.5 mm and 1.6 mm thick from top to bottom. 0.8 million
cells were added in each layer of the gel.

Cells within each layer were spread out and formed networks with the
neighboring cells after 5 days in culture, as demonstrated by F-actin staining (Figure
4.14A). Although connections between cells across two separate layers were not
observed, cells within the layer formed lumen like structures in the 3D collagen gels. This
was apparent in cross-sections of gels stained with Hematoxylin & Eosin (H&E) (Figure
4.14B). A representative immunofluorescence image further confirmed that the lumens
were lined with PECAM1 positive mESC-ECs (Figure 4.14C).
To check if the distance between the mESC layers will impact the formation of
lumens, gels with 0.2 mm and 0.5 mm distance between the cell layers were made.
Interestingly, it was observed that the number of lumens seemed to increase when the
distance between the mESC layers was reduced from 0.5 mm to 0.2 mm, as shown in
Figure 4.15.
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Figure 4.14 mESC-EC Behavior Inside Collagen Gels. (A) Rhodamine-phalloidin
conjugated F-Actin staining revealed formation of lumen-like structures by mESCECs cultured in a sandwiched 3D collagen gel. Scale bar: 100 µm (B) A crosssectional Hematoxylin and eosin (H&E) micrograph demonstrating lumen like
structures in both cell layers. Scale bar: 100 µm (C) Immunofluorescence image
confirming the presence of lumens lined by PECAM1 positive endothelial cells
(shown by yellow arrows). Scale bar: 50 µm

Figure 4.15 Lumen Formation in Static Gels. Lumen formation was observed in the
histology sections of the statically cultured mESC-EC gels. (A) shows the two mESCEC layer in the sandwich gel with the distance between the two cell layers being 0.5
mm while (B) shows the gel with the separating distance as 0.2 mm. The right panel
displayed an increased number of lumens compared to the left panel. Scale bar: 100
µm.
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Although lumen formation was observed in the collagen gels cultured, no interaction was
detected to occur between the two cell layers within the collagen gels. In an effort to
induce interaction between endothelial cell layers flow was applied to the collagen gels
using a previously described perfusion bioreactor setup [238]. The most noticeable
difference in the statically cultured gels and flow-cultured gels was the thickness of the
samples. When flow was initially applied to the collagen gels at the rate of 2 ml/min, a
significant compaction of the gel was observed. Collagen gels with a range of initial
thickness from 11 mm to 3.5 mm were tested and it was found that the final thickness
became less than 1 mm at the end of five days of flow as shown in Figure 4.16. The
flowrate was reduced to 0.5 ml/min to reduce the compaction and erosion of the gel under
the higher flowrate. Even with the application of flow no interbridging of the cell layers
was observed as shown in Figure 4.17.

Figure 4.16 Multi Layered Sandwich Collagen Gel Compaction Under Flow.
Collagen gels seeded with mESC experienced considerable compaction under flow.
The initial thicknesses tested ranged from 11 mm to 3.5 mm. After 5 days of flow,
considerable compaction was observed and the final thickness came down to less than
1 mm.
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Figure 4.17 mESC-EC Behavior inside Collagen Gels Under Flow. A cross-sectional
Hematoxylin and eosin (H&E) micrograph of a collagen gel cultured under flow
demonstrated lumen like structures in both cell layers. However, no inter bridging was
observed between the two cell layers Scale bar: 100 µm.
The expression pattern of AAT was analyzed in static and flow culture conditions.
Interestingly, it was found that while mESC-ECs in a traditional 2D culture do not
express AAT, they expressed AAT when cultured in a 3D collagen gel environment, both
under static and flow culture conditions as shown in Figure 4.18.

Figure 4.18 AAT Expression by mESC-ECs in 3D Culture System. Western blot
analysis shows the expression of AAT by mESC-ECs in collagen gels after 3 and 7
days of static as well as flow culture but not by mESC-ECs cultured in a 2D condition.
Beta actin served as a loading control. SD= mESC-EC collagen gel under static
conditions for Days 3/7, FD = mESC-EC collagen gel under flow for Days 3/7.
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Past studies have shown that VEGF promotes sprouting angiogenesis and has
been used by several groups to create vasculature in various culture systems. VEGF was
added in the culture medium at 5 ng/ml concentration and was used for culturing collagen
gels seeded with mESC-ECs in both static and flow culture conditions. Actin staining for
VEGF supplemented gels at Day 5 in static and flow culture conditions is shown in
Figure 4.19. A western blot performed on the VEGF supplemented gels and the control
gels showed the expression of eNOS by mESC-ECs in 3D culture conditions in static or
flow conditions (Figure 4.20).

Figure 4.19 Actin Staining on VEGF Supplemented mESC-EC Collagen Gels.
Multilayered sandwich collagen gels were cultured under static and flow culture
condition with or without the addition of VEGF for 5 dyas before being fixed and
stained with rhodamine-phalloidin conjugated f-actin (red). Scale bar: 100 µm.
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Figure 4.20 eNOS Expression in VEGF Supplemented Collagen Gels. A western blot
analysis shows the expression of eNOS in the VEGF supplemented gels cultured in
static and flow conditions at Day 5. Beta actin was used as a loading control.

4.4 Discussion
In this study, we describe the identification, isolation and characterization of a pure
endothelial cell population exhibiting islet microvascular endothelial cell phenotype
derived from mESC. These cells appeared as a side-product in mESC differentiation into
pancreatic beta cell culture following a previously established protocol [73]. This is a
unique finding, as differentiation was not achieved through a conventional direct
differentiation method, which uses successive maturation steps to derive endothelial cells.
While endothelial cells are recognized as a highly heterogeneous population exhibiting
different phenotypes and functions depending on the location of the endothelium within
the body [262], tissue-specific endothelial cell populations, especially derived from
pluripotent stem cells in vitro have not been demonstrated. Thus, to the best of our
knowledge, this is the first report on stem cell derived islet specific endothelial cells.
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The isolated mESC-EC population incorporates Dio-ac-LDL, which is a hallmark
of mature endothelial cells. In addition, they exhibit classical endothelial-specific markers
such as PECAM1, eNOS and thrombomodulin, which are essential to endothelial
adhesion and vascular network formation even at high passage numbers (p≥15). mESCECs also express EphB2, which is known to play an important role in sprouting
angiogenesis [263, 264]. Unlike a previous study that showed expression of PECAM1 by
mESC [261], our results demonstrated that neither our mESC nor cells during early
differentiation periods express PECAM1. Only cells selectively isolated from the
differentiation culture exhibited expression of PECAM1, indicating a pure population of
isolated endothelial cells. Endothelial cells are generally considered to exhibit
cobblestone morphology in culture; however these cells can vary in thickness, aspect
ratio, and orientation in vivo. In the presented study, the mESC-ECs initially had more of
an elongated morphology when first detected near insulin-producing cells, which is
consistent with previous reports on primary human and rat IECs [265]. Upon culturing in
endothelial cell medium, however, they progressed more towards a cobblestone like
morphology. As information on mouse IECs is currently lacking due to difficulty in
deriving purified IECs, whether the morphological changes induced any functional
changes needs further studies. However, detailed characterization of these cells was
performed on cultured mESC-ECs with cobblestone morphology and as the cells
possessed properties of islet specific endothelial cells, significant functional difference
due to morphological changes was not expected.
Pancreatic beta cells are unable to form a basement membrane in the absence of
IECs [154]. Instead, endothelial cells secrete proteins that are known to promote insulin
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producing cell proliferation and insulin regulation [118, 154, 205]. IEC secreted collagen
type IV is shown to potentiate insulin secretion via interaction with integrin α1β1 on beta
cells [266]. Likewise, laminin has been shown to up-regulate insulin gene expression and
secretion and induce beta cell differentiation and proliferation [154, 155, 267]. Through
immunohistochemical analysis, it was found that mESC-ECs in close proximity to insulin
positive cells deposit collagen type IV and laminin during differentiation culture. Isolated
mESC-ECs in culture also secret ECM proteins such as fibronectin, laminin, and collagen
type IV. This further confirms their endothelial cell phenotype and provides additional
evidence for possible interactions of mESC-ECs with the pancreatic beta cell populations.
Although the cells formed lumens in 3D collagen gels, cell branching between the
two layers was not observed. Application of flow and addition of VEGF was
hypothesized to induce the cell branching. Actin staining in the flow gels and the VEGF
supplemented gels revealed a more tortuous structure of cell networks but histological
sections did not reveal connections between the two cell layers (data not shown).
It has previously been shown that VEGF plays an important role in recruitment of
endothelial cells and formation of IEC fenestrations [149, 268-270]. Our results
demonstrate the presence of VEGF in the culture medium during differentiation, which
progressively increases with more days in culture. This increased concentration of VEGF
coincided with the increased number of mESC-ECs. As our populations of endothelial
cells were detected in the vicinity of insulin-producing cells, it is plausible that the
signals originating from endodermal pancreatic cells induced formation and growth of
endothelial cell population in the differentiation culture. Since it was found that mESCECs do not produce significant amounts of VEGF in culture and pancreatic beta cells are
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known to constitutively secrete VEGF to recruit endothelial cells [154], it is likely that
VEGF is mostly originated from insulin producing beta cells in our culture. Moreover, as
IECs are known to constitutively express VEGF-R1 (Flk-1) [271-273] enabling them to
bind to VEGF, the expression of FLK1 by our isolated mESC-ECs further supports the
hypothesis that pancreatic beta cells plays an important role in endothelial cell growth
although the exact mechanisms involved needs to be further elucidated. Addition of
Thalidomide, an angiogenesis inhibitor [260] substantially suppressed the formation of
mESC-ECs in our culture. Future studies with addition of VEGF receptor antagonists in
the culture medium will be necessary to ascertain the role of VEGF in mediating the
formation of mESC-ECs in the differentiation culture.
In addition to classical endothelial cell phenotype, mESC-ECs exhibit distinct
functional characteristics of IECs that are manifested by unique markers that can aid in
their identification. mESC-ECs express nephrin, which is considered one of the specific
IEC marker as shown by Zanone et al. [265]. While nephrin is expressed by other cell
types including podocytes in kidneys [274], some parts of the central nervous system in
mice [275, 276] and by the Sertoli cells where it forms the blood-testis barrier [277],
other tissue-specific endothelial cells have not been shown to express nephrin. The
precise function of nephrin on IECs however, remains unknown. Studies have also shown
that AAT is another IEC specific marker that is not expressed by endothelial cells in
surrounding tissues [278]. A study by Zhang et al. showed that AAT significantly reduces
cytokine and streptozotocin induced pancreatic beta cell apoptosis [279]. Additionally, the
administration of clinical grade AAT after islet transplantation has been shown to improve
the graft survival in mice [280, 281]. While our mESC-ECs cultured in traditional 2D
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condition do not express AAT, it is important to note that mESC-ECs cultured in a 3D
collagen gel environment express AAT. As endothelial cells may lose some of their
phenotypical characteristics when maintained in a 2D culture condition, it is possible that
mESC-ECs cultured in a 3D condition regained their AAT expression, which was originally
down-regulated from long-term 2D culture. This indicates the need for a physiological
microenvironment to maintain phenotype and function of cells in vitro.
Moreover, IECs are known to produce a host of vasodilators including nitric
oxide (NO) [143]. NO is generated by NO synthase (NOS) and eNOS is the major NOS
isoform predominantly expressed in endothelium. Both constitutive and cytokine induced
eNOS are present in pancreatic islets, although the role of constitutive eNOS in beta cell
physiology has been controversial [282]. Studies using islet cells and beta cell lines have
reported that the constitutive eNOS either stimulates [283-288] or inhibits [289-295] the
insulin release. Unlike other endothelium, constitutive and cytokine inducible eNOS in
islets is specifically upregulated depending on glucose levels [282]. Thus, the fact that
our mESC-ECs express eNOS, which is regulated by glucose levels of 25-35 mM in the
culture medium, further demonstrates their behavior as IECs. However, eNOS expression
was not significantly upregulated in culture medium containing 17.5 mM of glucose,
which is much higher than physiological glucose levels for endothelial cells at 4mM6mM [167, 296, 297]. Since mESC-ECs were cultured using medium containing 17.5
mM of glucose, it is plausible that cells have become insensitivity to that glucose level
from being exposed for prolonged time. Thus, additional stimuli such as cytokines may
be required to induce cells to produce eNOS at that level.
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Given the increasing interest in tissue-specific endothelial cell populations, the
availability of an unlimited source of IECs derived from pluripotent stem cells provide a
promising source of cells for both research and clinical use. Although primary endothelial
cells are widely used in in vitro studies, stem cell-derived endothelial cells, especially
organ-specific endothelial cells, provide the opportunity to further study their specific
functions in in vitro conditions. Better understanding of mESC-EC function and their
interaction with their neighboring pancreatic beta cells can lead to significant
advancements in the development of therapeutic strategies for diabetes treatment.
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CHAPTER 5
SUMMARY AND FUTURE DIRECTIONS

In summary, this thesis describes methods to develop 3D engineered tissue system as an
in vitro model to enhance survival and function of IPCs derived from mES cells. First of
all, IPCs were successfully derived from mouse embryonic stem cells. Not only did the
differentiated IPCs expressed beta cell specific markers such as FoxA2, Sox17, Pdx1,
Insulin, C-peptide, Pax4, Nkx6.1, Glut2 and EphrinA5, but they also displayed glucose
responsiveness when exposed to low and high concentrations of glucose. The
differentiation yield of the IPCs was however only 5.76%, suggesting that further
optimization to the protocol is needed to improve the efficiencies. It was further observed
that the yield increased significantly upon increasing the duration of culture by additional
7 days suggesting that culture duration was an important factor governing the
differentiation yield. It is also critical to identify other cell types that are present in the
culture as they may play a supporting role in the development of IPCs. Tumor formation
was not observed in the cultures in in vitro condition but the possibility of tumor
formation in in vivo condition needs to be examined.
Secondly, simple 3D engineered tissues were developed to mimic the native
environment that the islet cells reside in. The 3D collagen tissue environment allowed
better maintenance of IPC viability for up to 5 days compared to IPCs on a poly-ornithine
and laminin coated surface. However, IPCs lost their glucose responsiveness in 3D
condition. Their basal insulin level was 10 µg/ml, but this level did not increase when
exposed to a high glucose condition. There are several possible factors that may attribute

126

to this functional change. When IPCs are selectively picked from the culture to form 3D
tissues, they are being removed from the other cell types in the differentiated culture as
well as from basement membrane proteins deposited by other cells. The presence of
other cell types and ECM proteins not only play a supporting role in the development of
the IPCs but also, may be instrumental in the maintenance of beta cell specific
characteristics. In addition, as islet ECM is richly populated with laminins, collagen type
IV and several proteoglycans, collagen gel supplemented or immobilized with ECM
proteins may improve the glucose responsiveness of isolated IPCs in 3D tissue
environment. Another factor that may have contributed to the loss of glucose
responsiveness is the glucose concentration of the culture medium used. Past studies have
reported evidence that exposure to high glucose medium de-sensitized rat and human
islets and impaired their function in response to a glucose challenge [221, 244, 245]. The
medium used in this study contained about 17.5 mM of glucose and as this is
considerably higher than the physiological level of 4-6 mM, it is possible that the cells
were rendered glucose unresponsive because of exposure to the medium used. Transition
to low glucose conditions during final stages of differentiation can also be employed to
improve glucose responsiveness as has been previously [76].
It has also been suggested that during development mesenchymal cells surround
the budding pancreas and their loss impairs the development and proliferation of insulin
producing beta cells [298] because the pancreatic mesenchyme and the innervating neural
cells govern important aspects of the pancreas organogenesis [298-300]. Beta-cell
phenotype is easily lost upon removal from their native environment [301, 302].
Identification of this supporting cell population in the differentiation culture will be an
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important step in making the IPCs glucose responsive. If this cell population is identified
it can be used for potential co-culture with IPCs to improve their outcome in 3D culture
systems.
To facilitate nutrient diffusion and gas exchange on IPCs in 3D collagen tissues,
perfusion flow was applied for 5 days in culture. A flowrate of 0.5 ml/min was chosen for
our study. Although this flowrate translates in the microvasculature to a shear stress of
~0.71 dyne/cm2 [238], it is considerably higher than the flowrate in rat islets i.e., 2 x 10-5
ml/min [142, 243]. Higher cell death was observed in tissues exposed to flow compared
to statically cultured tissues. The outcome with a lower flow-rate or shorter culture
duration might be very different. It is also possible that IPCs inherently do not have a
favorable response to flow application. Studies have provided evidence of the detrimental
behavior of epithelial cells to flow exposure [303]. As beta cells are of epithelial origin, it
is possible that they behave poorly under flow culture condition. Thus, various
parameters including different flowrates, stiffness of the tissue, cell concentrations, etc.
need to be carefully examined and optimized to decide the most suitable culture
condition.
Since islet beta cells are in close relation to vascular endothelial cells, mES
derived IPCs were co-cultured with ECs in 3D collagen tissues to provide a more
physiological environment to the IPCs. It was found that the co-culture with mESC-ECs
improved survival of the IPCs in both static and flow culture condition. However, the coculture tissue was not glucose responsive from 5 days in culture. A similar behavior was
observed for co-culture gels under flow condition. Extending the co-culture duration to
14 days might improve the glucose responsiveness, as longer culture duration increased
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the glucose, responsiveness in a previously reported study [304]. Although the ECs
appeared spread out in the co-culture tissues as visualized through live dead staining,
advanced characterization of the co-culture tissue to assess the degree of vascularization
is required. Histological sectioning of the co-culture tissue and further staining for cell
specific markers will be important to study the interactions between IPCs and ECs.
It was found that the mESC derived IPCs and ECs expressed EphrinA5 and
EphB2, respectively. EphB2 is expressed by ECs and EphrinA5 is present on beta cells
and it has been shown that these proteins interact with each other with high affinity [236].
EphB2 was found highly upregulated in mESC-ECs when they were plated on Matrigel
suggesting that it might play a role in vasculogenesis. EphrinA5 expression was observed
in IPCs in all different culture conditions and did not show significant changes upon
application of flow. The interaction between these two proteins was not analyzed. As
EphrinA5 is important in beta cell-to-cell communication and in glucose sensing it will
be interesting to see how its expression changes at different culture conditions and
whether the presence of ECs can enhance the expression of EphrinA5.
Thirdly, mESC-ECs were identified in close vicinity of IPCs and isolated from the
IPC differentiation culture. The isolated and cultured mESC-EC population was found to
be highly pure. These cells exhibited characteristics unique to the islet endothelium with
the expression of nephrin, Flk-1 and AAT in addition to the expression of classical
endothelial cell markers. Moreover, these cells regulate their eNOS levels based on
glucose levels. The mESC-ECs also showed cord formation on Matrigel and upon
embedding inside collagen gels, which is a classic behavior of endothelial cells. An
increasing VEGF gradient with days in culture corresponded with increased number of
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mESC-ECs, suggesting that VEGF might play a role in the derivation of ECs. Upon
addition of thalidomide, a potent angiogenesis inhibitor, the number of ECs was greatly
reduced in culture. This is the first demonstration of a tissue specific endothelial cell type
derivation from mES cells and is completely novel. The derivation of such specialized
endothelial cells creates exciting opportunities to study their function in in vitro
conditions as well as their interactions with the tissue specific cells – beta cells in this
case.
It is important to note that there are some inherent limitations of the culture
system. The total cell population in the co-culture tissues is formed by IPCs and mESCECs, while the 2D culture was formed entirely of IPCs. Hence, gene expression of beta
cell specific markers appears lower than its actual value in the co-culture samples. To
accurately compare the gene expression levels in both the conditions a 2D co-culture of
mES derived IPCs and ECs is required. This can be effective in teasing apart the specific
effects of co-culture and 2D vs. 3D environment. Gene expression analysis studies
revealed that insulin gene expression was significantly higher in the co-culture in static
condition compared to flow condition. Further studies are needed to determine the effects
of culture conditions and application of flow on beta cell specific gene expression.
Moreover, additional studies are needed to determine whether IPCs can gain glucose
responsiveness upon transplantation in concurrence with previous studies [95, 172].
In conclusion, the presented study demonstrates useful strategies to develop a 3D
insulin producing tissue using mES cells. While no significant improvements were seen
in the glucose responsiveness in 3D culture conditions in static or flow culture conditions,
this study describes includes preliminary design considerations that can be further
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extended in developing functional 3D insulin-producing tissues, and ultimately
establishing a long-term clinically relevant strategy. The presented approach will need to
be optimized to develop a clinically relevant cell therapy for diabetes in the future.
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APPENDIX A

CELL CULTURE MEDIUM RECIPES
The following appendix has the culture medium recipes used for all the presented studies.
All mediums were prepared in volumes of 500 ml-1000 ml and were stored at 4 °C.
Mediums were prepared in sterile glass bottles and were used within 2-3 months of
preparation.
Mouse embryonic fibroblast (MEF) culture medium:
DMEM (High Glucose)
FBS
100 X L-Glutamine
100 X Pen./Strep.
100 X NEAA
100X Na-pyruvate

500 ml, Life Technologies, 11965-084
58 ml, Life Technologies, 16000044
5.8 ml, Life Technologies, 25030
5.8 ml, Life Technologies, 15140
5.8 ml, Life Technologies, 11140
5.8 ml, Life Technologies, 11360

Mouse embryonic stem cell culture medium
DMEM (High Glucose)
Knock Out Serum Replacement
100 X L-Glutamine
100 X Pen./Strep.
100 X NEAA
100X Na-pyruvate
2-Mercaptoethanol

500 ml, Life Technologies 11965-084
90 ml, Life Technologies 10828
6 ml, Life Technologies ,25030
6 ml, Life Technologies, 15140
6 ml, Life Technologies,11140
6 ml, Life Technologies, 11360
4.4ul, Sigma, M6250

It is recommended that LIF is freshly thawed out and added to the media just before use
(100 ul/ 50 ml of medium).
Differentiation medium #1
IMDM
FBS
100 X L-Glutamine
100 X Pen/Strep.
1-Thioglycerol

400 ml, Life Technologies, 12440-061
100 ml, Life Technologies, 10828
5 ml, Life Technologies, 25030
5 ml, Life Technologies, 15140
3.9 ul, Sigma, M6145
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Differentiation Medium #2
DMEM/F 12 medium
Progesterone
Putresciene
Laminin
Nicotinamide
Insulin
Sodium Selenite
Apo transferrin
B 27
Penn Strep

1000 mls, 12500-062
10 ul [Stock 2mM; Final conc. 20 nM, Sigma]
100 ul [Stock 1M; Final conc. 100 uM, Sigma]
1 ml, Sigma L2020
1 ml [Stock : 1M; final conc. 10mM, Sigma]
6.25 ml, Life Technologies, 12585-014
100 ul [Stock: 300 uM; Final conc 30 nM, Sigma]
50 mg, Sigma T1147
20 mls, Life Technologies, 17504-044
10 mls, Life Technologies, 15140

Endothelial cell culture medium
MCDB 131 Medium
FBS
Penn Strep
Endogro

1000 ml, Sigma, M8537
100 ml, Life Technologies, 10828
10 ml, Life Technologies, 15140
4 ml, VEC Technologies
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APPENDIX B

REAGENT RECIPES
This appendix describes the recipes for the various reagents used for all the presented
studies. All reagents were were stored at 4 °C. Mediums were prepared in sterile glass
bottles and were used within 2-3 months of preparation.
Krebs Ringer Bicarbonate Hepes (KRBH) Buffer:
Solution A:
Sodium Chloride
Potassium Chloride
Monopotassium Phosphate
Calcium Chloride
Magnesium Sulfate Heptahydrate
De-Ionized (DI) Water

6.92 gm.
0.36 gm.
0.16 gm.
0.38 gm.
0.3 gm.
200 mls.

Solution B:
Sodium Bicarbonate
DI Water

2.08 gm.
160 mls.

Solution A
Solution B
HEPES
BSA

200 mls.
160 mls.
2.4 gm.
2 gm.

All the contents were mixed and the volume was increased to 1 liter by adding DI water.
The pH was adjusted to 7.4 and the solution was filtered through a 0.22 µm filter. The
KRBH buffer was then stored at 4°C.
All the reagents were purchased from Sigma unless otherwise stated.
Blocking Buffer for Western Blot Applications
A 5% BSA solution was prepared using TBS-Tween buffer (Boston Bioproducts). The
solution was placed on a magnetic stir plate till the BSA was completely in solution. The
solution was stored at 4 °C.
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Blocking Buffer for Immunofluorescence and Immunohistochemistry
A 10% goat serum solution was made in PBS. This solution was made and used fresh.
Lysis Buffer Cell Lysate Preparation
RIPA Buffer
Protease Inhibitor
Triton-X 100

500 µl
5 µl
5 µl
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APPENDIX C

PROTEIN ASSAY PROTOCOLS
This appendix describes the protocol used to the protein quantification using Bradford
assay and DC assay.
Bradford Protein Assay:
Bradford reagent will be needed to perform this assay.
1.
2.
3.
4.
5.
6.

Prepare and label the correct number of cuvettes: # of your sample + 1 blank + 7
BSA standards (0.125mg/mL, 0.25 mg/mL, 0.5 mg/mL, 0.75 mg/mL, 1 mg/mL, 1.5
mg/mL, 2 mg/mL).
Add 20ul of each sample, standards or RIPA buffer to the cuvettes.
Add 1 ml of Quick Start Bradford Dye Reagent, warmed to room temperature, into
each cuvette. Pipette well to mix. At this point a color change will be observed.
Incubate 5 minutes a room temperature before further processing.
Start up the BioRad smart Spec plus Spectrophotometer.
Measure the absorption values and the concentration of the sample.

DC Protein Assay:
A DC Assay kit will be needed to perform this assay.
1.

2.
3.
4.
5.
6.

Add 20 µl of reagent S to each ml of reagent A that will be needed for the run. This
is called working reagent A’.
Prepare and label the correct number of cuvettes: # of your sample + 1 blank + 7
BSA standards (0.125mg/mL, 0.25 mg/mL, 0.5 mg/mL, 0.75 mg/mL, 1 mg/mL, 1.5
mg/mL, 2 mg/mL).
Pipet 20 µl of standards and samples into cuvettes.
Add 100 µl of reagent A or A’ into each tube.
Add 800 µl of reagent B into each test tube and vortex immediately.
After 15 min incubation, absorbance can be read at 750 nm.
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APPENDIX D

MISCELLANEOUS PROTOCOLS
The following protocol to remove the paraffin coating from histology slides before they
were used for immuostaining purposes. It also describes the FACS staining protocol.
De-paraffinization protocol:
1.
2.
3.
4.
5.
6.
7.
8.

Wash slides 2X in Xylene for 5 min each.
Wash slides 1X in 100% ethanol for 5 min.
Wash slides 1X in 95% ethanol for 5 min.
Wash slides 1X in 80% ethanol for 5 min.
Wash slides 1X in 70% ethanol for 5 min.
Wash slides 1X in 50% ethanol for 5 min.
Wash slides 2X in DI water for 5 min each.
Proceed to permeabilization and staining.

FACS Protocol :
1. Trypsinize and count cells. Use 5x105 to 1x106 cells per 5 ml polystyrene roundbottom tube.
2. Centrifuge the cells to remove the medium.
3. Add ice cold 4% PFA to the cells and allow them to sit for 30 min.
4. Centrifuge and remove the PFA, add 1 ml PBS and spin at 1500 rpm. Discard the
PBS and repeat the process 3 times.
5. Add 0.25% Triton X and allow to incubate at RT for 5 min. Do not exceed 5
minutes.
6. Add cold PBS and centrifuge at 1500 rpm for 5 min. Drain the supernatant and resuspend the cells in 100 µl of cold FACS buffer (PBS + 1% BSA+ 2mM EDTA).
Avoid any cell clumps.
NOTE: Include blank and isotype controls. Blank is just the FACS buffer, and
isotype control is cells having just the secondary antibody on them. Blank and
isotype control are also fixed and permeabilized. This protocol involved fixing
and permeabilization, as the antibody was specific to an intracellular epitope.
7. Allow cells to sit at 4 °C for 10 minutes in the FACS solution, which is also the
blocking solution.
8. Add primary antibody directly in the cells + FACS buffer. For CD-31; use 5 µl for
100 µl of FACS buffer.
9. Incubate at 4 °C for 30 minutes over ice.
10. Add 1 ml cold PBS to the tube. Centrifuge at 1200 rpm for 7 minutes at 4 °C.
Discard supernatant.
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11. Resuspend in 1 ml cold PBS. Centrifuge and discard the supernatant.
12. Resuspend in 100 µl FACS buffer.
13. Add secondary antibody directly to the cells + FACS buffer mix. Use 5 µl for 100
µl of FACS buffer
14. Incubate at 4 °C for 30 minutes over ice.
15. Add 1 ml of cold PBS to each tube. Centrifuge and discard the supernatant.
16. Resuspend in 1 ml cold PBS. Centrifuge and discard the supernatant.
17. Resuspend in 0.3 ml PBS (same amount per tube). Keep at 4 °C until ready for
FACS analysis. (Use less than 0.3 ml if low cell count).
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